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For My Parents and Dan  
Abstract 
 Nucleic acids are fundamental biomolecules responsible for all activities of a living cell. 
DNA serves as an instruction manual to the cell, containing blueprints and directions for all 
cellular processes, while RNA serves to carry out the messages held within DNA. Research into 
the structure, stability, and function of nucleic acids has revealed much about the origin and 
evolution of life.  
 The ultimate goal of this work is to understand how molecules bind and associate within 
the minor groove of double stranded, helical DNA. A series of 2′-deoxyadenosine analogues are  
modified at the three position by replacing the N3-nitrogen with carbon. Substitution at this 
position is designed to emulate the effects of removing hydrogen bond acceptors, introducing 
steric bulk, and tethering functional groups of interest into the minor groove. These functional 
groups mimic small molecules that have been shown to bind within the minor groove of A-T rich 
sequences as well as serve as a platform for further substitution by fluorescent tags. 
 The synthetic effort needed to obtain purine nucleosides containing each of these 
modifications was non-trivial. New methodologies unveiled directing and protecting strategies 
towards the desired isomer of these modified nucleosides in higher yields than those previously 
deemed acceptable. Application of these modified nucleosides into duplex DNA reveals 
thermodynamic parameters for how small molecules bind to the minor groove and the effects of 
introducing biomarkers into an unprecedented region of DNA. 
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Abbreviations and Acronyms 
A adenosine  
Ac acetyl  
Ad adenine  
AIBN azobis(isobutyronitrile)  
Bn benzyl  
Boc tert-butyloxycarbonyl  
Bz benzoyl  
calcd calculated  
CD circular dichromism  
d day(s)  
dA 2′-deoxyadenosine  
damc3A 3-deaza-3-aminomethyl-2′-deoxyadenosine 
DABCO 1,4-diazabicyclo[2.2.2]octane  
DAP 2,6-diaminopurine  
DBN 1,5-diazabicyclo[4.3.0]non-5-ene  
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene  
dC 2′-deoxycytidine  
dc3A 3-deaza-2′-deoxyadenosine  
DCM dichloromethane  
dG 2′-deoxyguanosine  
dhmc3A 3-deaza-3-hydroxymethyl-2′-deoxyadenosine  
DIPEA diisopropylethylamine  
DMAP 4-(dimethylamino)pyridine  
DMF N,N-dimethylformamide  
dmc3A 3-deaza-3-methyl-2′-deoxyadenosine 
DMT 4,4′-dimethoxytrityl  
DMSO dimethylsulfoxide  
DNA β-D-2′-deoxyribonucleic acid  
dtmc3A 3-deaza-3-thiomethyl-2′-deoxyadenosine 
Et2O diethyl ether  
EtOAc ethyl acetate  
equiv equivalents  
G guanosine  
Gn guanine  
h hour(s)  
Hex hexanes  
HPLC high performance liquid chromatography  
HRMS high-resolution mass spectrum  
M4SA 2,2,3,3-tetramethylsuccinic anhydride  
M4SI 2,2,3,3-tetramethylsuccinimide  
M molar  
min minute(s)  
NMR nuclear magnetic resonance  
NBS N-bromosuccinimide   
PAGE polyacrylamide gel electrophoresis  
Pht phthaloyl  
pyr pyridine  
Rf retention factor  
rt room temperature  
T thymidine  
TBAF n-tetrabutylammonium fluoride  
TBS, TBDMS tert-butyldimethylsilyl  
TCA trichloroacetic acid  
TEA triethylamine  
Tf triflate (trifluoromethanesulfonyl)  
TFA trifluoroacetic acid  
TLC thin layer chromatography  
TMS trimethylsilyl, also tetramethylsilane  
Tol para-toluoyl  
Tr trityl (triphenylmethyl)  
Ts tosyl  
RNA β-D-ribonucleic acid  
U uridine  
UV Ultraviolet 
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Chapter 1: Introduction 
1.1 Early Nucleic Acids Research  
Nucleic acids are the foundation and basis of all life forms. The oldest fragment 
of DNA dates back over 400 million years ago and is from the time when bacteria ruled 
Earth.1 Today, nucleic acids research has become prominent in a diverse set of fields. Its 
applications in medicine, agriculture, and nanotechnology have demonstrated its 
widespread function to benefit society. Its role and the molecules associated with DNA 
allow us to understand life on a level that was not possible 150 years ago. Meischer was 
the first to discover DNA in 1869 by exposing the nucleus of a cell to alkaline and acid 
conditions, leading to the formation of a precipitate.2 At the time, it was referred to as 
nuclein, since it is mainly stored in the nucleus of the cell. Over the next 30 years, 
important discoveries regarding the components of the newly coined “nucleic acids” and 
the enzymes associated with them led to a Nobel Prize in Physiology or Medicine to 
Albrecht Kossel in 1910. Kossel is credited with deciphering the genetic code of DNA 
into its four monomers: 2′-deoxyadenosine, 2′-deoxythymidine, 2′-deoxyguanosine, and 
2′-deoxycytidine.3 It would later be revealed that these monomers form long chains 
through phosphodiester linkages (Figure 1). The structure and role of DNA within the 
cell was further elucidated in the following years. Proof that DNA is hereditary material 
came in 1944. Avery, MacLeod and McCarty extracted viral DNA from pathogenic 
Streptococcus pneumonia and transformed it into a non-viral strain of the same bacteria.4 
The non-viral bacteria became virulent after transformation, demonstrating that DNA is 
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Figure 1. A structure of a polynucleotide containing the four residues (dA, dG, dC, and dT) as they 
would appear in DNA.  In, RNA, the 2’-hydroxyl is present on all sugars and U pairs with A instead of dT. 
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the material responsible for genetic differences within the same organism, not proteins or 
other cellular components.  
The discovery of the double-helical structure of DNA is widely credited to 
Watson and Crick in 1953. This discovery would not be possible without previous results 
by Astbery, Bell, Chargaff, and Wilkins. In 1938, Astbery and his graduate student,  
 
 
 
 
 
 
Florence Bell, showed that the bases in a DNA molecule are stacked one above the other 
and lie perpendicular to the long axis of the molecule “as if they were a pile of pennies”.5 
“Chargaff’s Rule” states that the number of pyrimidines is equal to the number of purines 
within DNA,6 suggesting some type of pairing between the two heterocycles. In 1953, 
Franklin and Wilkins were the first to obtain an X-ray crystal structure of DNA and 
publish it in Nature (Figure 2).7 The analysis demonstrated that DNA has a regularly 
repeating structural unit every 3.4 Å, with a complete turn of the axis occurring every 34 
Å, or every 10 bases. Without knowledge of this crystal structure, Watson and Crick 
Figure 2. X-ray diffraction pattern of DNA obtained by Wilkins and Franklin.7 
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wrote to Nature describing a model structure for DNA that is still used today.8 They 
described the structure as a double helix that is held together by a pairing system. There 
are two base pairs in DNA: dA pairs with dT and dG pairs with dC (Figure 3). Their 
proposed secondary structure directly supported a copying mechanism of the primary 
structure and a means of passing genetic information from generation to generation. This 
discovery transformed nucleic acid research forever and has allowed scientists to 
discover key functions of DNA as genetic material.  
 
 
 
 
 
  
Figure 3. The two Watson-Crick base pairs present in DNA. In RNA, U replaces T.  
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1.2 Nucleic Acid Structure 
The discovery of the double helix by Watson and Crick opened a door to 
researchers studying nucleic acids. The secondary structure allowed researchers to go in 
two opposing directions: microscopic, examining the molecular structure of each 
monomer and macroscopic, examining how nucleic acids behave as macromolecules. 
While many foundations been laid, how the microscopic structure affects the 
macroscopic structure is still a current focus of nucleic acids research and is a main 
theme of the work described in this thesis. 
From a molecular point of view, nucleic acids are composed of building blocks 
referred to as nucleotides (Figure 1). Each nucleotide has three key features: a 
nucleobase, a sugar, and a phosphate group. If the pyrimidine or purine is free, it is 
referred to as a nucleobase. Once coupled to a sugar, they are referred to as nucleosides 
(Table 1).   
Table 1. Nucleic Acids Nomenclature 
Nucleobase Nucleoside Example of Nucleotide 
Guanine Guanosine Guanosine-5′-monophosphate 
Cytosine Cytidine Cytidine-3′-monophosphate 
Adenine Adenosine Adenosine-3′,5′-bisphosphate 
Thymine Thymidine Thymidine-5′-triphosphate 
Uracil Uridine Uridine-2′-monophosphate 
 
In nature, guanine, cytosine, and adenine are coupled to both ribose and 2-deoxyribose 
sugar moieties. The nomenclature in Table 1 is for ribonucleosides. If these bases are 
coupled to 2-deoxyribose, the names of these nucleosides are simply prefixed with 2′-
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deoxy. It is important to note that in the cell, thymine is coupled with 2-deoxyribose to 
produce thymidine (dT) and uracil is coupled with ribose to produce uridine (U). The 
form of sugar is assumed within the nomenclature for these two nucleosides.  
Nucleotides are linked by a single phosphate group bridging the 3’-hydroxyl of 
one monomer to the 5’-hydroxyl of the next monomer by a phosphodiester bond, as 
shown in Figure 1. These linkages impart stability and longevity to nucleic acids and are 
a key reason why they have evolved to store and pass genetic information from one cell 
to another over multiple generations. Phosphodiester linkages are negatively charged at 
neutral pH which prevents them from crossing cellular membranes, holding them within 
the nucleus of the cell. Their inherent negative charge offers kinetic stability to 
nucleophilic attack, providing resistance to hydrolysis, which explains how these 
molecules have lasted millions of years in an aqueous environment with little damage to 
their integrity.9   
Multiple nucleotides linked together form single strands of ribonucleic acids 
(RNA) or deoxyribonucleic acids (DNA). Nucleic acids are capable of forming a diverse 
set of secondary structures (Figure 4).10 Depending on the sequence, they can fold back 
and base pair with themselves to form β-hairpins. The sequence of this type of structure 
is typically palindromic, which imparts its self-complementary character. The β-turn of 
the hairpin requires a minimum of 3 nucleotides to form a stable structure. Non-
palindrome sequences can still form hairpins, but these structures are naturally less stable 
due to bulges of unpaired nucleotides. Non-palindrome sequences prefer to pair with a  
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second strand of DNA/RNA containing the complement to form double stranded 
DNA/RNA. The two complementary strands run antiparallel (i.e. 5’3’ complements 
with 3’5’ strands) with the phosphodiester linked sugars forming an external, anionic 
backbone. The nucleobases lie perpendicular to the backbone, stacked upon one another 
to form a hydrophobic core.  The formation of the helix results in two grooves. These two 
grooves are commonly referred to as the major and minor grooves (Figure 5a). Imagine 
the phosphate backbones of each strand lying on the perimeter of a circle, with the base 
pairs cutting across the diameter of the circle. The grooves are defined as the distance on 
the circle between the phosphates on the backbone, with the larger being the major 
groove and the smaller the minor groove. The base pairs are arranged in such a way that 
certain functional groups are characteristic to each groove (Figure 5b). For example, the 
methyl group on thymine is located in the major groove, while the amine on guanosine is 
pointed towards the minor groove. Differing sequences of DNA have different patterns of  
Figure 4. Various secondary structures of DNA.10 
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functionality within their grooves that biomolecules, small molecules, and cations use as 
a fingerprint to bind to DNA with sequence specificity.  
The helix itself can take on different macroscopic structures depending on the 
conformation of its monomers. The three predominant forms of nucleic acids are A-, B-, 
and Z- forms (Figure 6). Other forms of DNA have been described within the literature, 
but exist under atypical conditions.11 There are many unique characteristics to each form 
of helix which arise from various components within the structure of the monomer. 
Before discussing the structural aspects of A-, B-, and Z- form nucleic acids, it is 
important to review these components. 
Figure 5. a) Major and minor grooves of a double helix. b) Major and minor grooves of A-T (above) and 
G-C (below) base pairs and the functional groups that lie in each. 
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The major component affecting the conformation of the helix is the sugar pucker 
of each monomer. The five atoms within a furanose ring rarely exist in the same plane; 
one or two atoms typically lie out of the plane. D-Ribose and 2-deoxy-D-ribose 
predominantly exist in two types of sugar pucker, C3′-endo and C2′-endo, which are 
responsible for A- and B-form nucleic acids, respectively (Figure 7a). Less commonly 
observed is the C2′-exo sugar pucker which is found in Z-form DNA. Another component 
of each monomer’s conformation is the orientation of the nucleobase with respect to the 
Figure 6. A-, B-, and Z- duplex structures. Above: top-down view of the helix. Below: Side 
view of the helix.12 
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sugar. This orientation changes by rotation about the glycosidic bond. Nucleosides prefer 
to exist in anti-orientation, where the Watson-Crick hydrogen-bonding face of the 
nucleobase is pointed away from the sugar. In syn-orientation, the hydrogen-bonding face 
is pointed over the sugar. This orientation is typically disfavored due to sterics of the 
nucleobase with the 5’-carbon on the sugar (Figure 7b). The sugar pucker and orientation  
of the nucleobase have an additive affect on each base pair, leading to a global effect on 
the helix. 
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A-, B- and Z- form helices are easily identifiable from one another by examining 
their crystal structures. The diameter and depths of the grooves in each helix are 
noticeably different between forms. Perhaps more subtle is the positioning of the base 
pairs. There are many parameters available to describe the location of the base pairs 
within the helix (Figure 8). Most important for describing the base pairs within each 
conformation of helical DNA are inclination, propeller twist, and twist. Inclination refers 
to a degree of rotation about the vertical axis of the base pairs, where 0o infers the base 
pairs are perpendicular to the vertical axis of the helix. The heterocycles in Watson-Crick 
  
Figure 8. Structural parameters used to describe base pair positioning. Figure adopted from Principles 
of Nucleic Acid Structure by Wolfram Saenger 
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base pairs are not coplanar and the degree to which the bases are rotated is referred to as 
propeller twist. This is not to be confused with twist, the degree of which each base pair 
is rotated from the previous base pair along the length of the helix. Other parameters 
include rise, the distance between each base pair along the helical axis, and pitch, the 
measured distance of one full turn of the helix. Each form of helix has “hallmark” 
characteristics that are discussed below.  
A-form is a right-handed helix with the widest diameter and smallest rise per base 
pair of any form, both attributed to the sugar pucker. The C3′-endo sugar pucker places 
the 3′- and 5′- hydroxyls within 5.9 Å of one another, leading to its small rise and wide 
diameter. The large diameter places the base pairs off-center of the vertical axis, resulting 
in an exaggerated major and diminished minor grooves. The major groove is very deep, 
while the minor groove is extremely shallow. Base pairs in an A-form conformation are 
on a severe incline of +19o. RNA-RNA or RNA-DNA helices appear to exist 
predominantly in A-form due to the presence of the 2′-hydroxyl on ribose. This hydroxyl 
places the sugar in a C3′-endo conformation, which allows intramolecular hydrogen 
bonding to the C4′-oxygen within the ring of the furanose. In order to observe A-form 
DNA-DNA helices, dehydrating conditions of high salt and duplex DNA are required. 
These are common crystallization conditions, so it remains unclear as to whether or not 
DNA-DNA helices exist in A-form under normal cellular conditions.  
DNA-DNA helices primarily exist as B-form structures within the cell. B-form 
DNA is more narrow and elongated than A-form due to C2′-endo sugar puckering 
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placing the backbone hydroxyls 7.0 Å apart. This form of helical DNA places the base 
pairs on the center of the vertical axis, resulting in more equally sized major and minor 
grooves. The base pairs are nearly perpendicular to the vertical axis of the helix with a 
small inclination of -1.2o. B-form DNA is less distorted and more symmetrical than both 
A- or Z-form helices. 
Z-form helices are plausibly the most distorted form of DNA within cellular 
conditions. Its role in nature has been difficult to elucidate, but is thought to relieve 
supercoiling of DNA while transcription occurs.13, 14 This helix is left-handed in nature 
and generally disfavored. Alternating poly(dGC) sequences in the presence of high salt 
can encourage B- to Z-form transitions. Interestingly, the sugar pucker in these 
alternating poly(dGC) sequences is C2′-endo for dC residues and C2′-exo for dG 
residues. Z-form DNA is the only naturally occurring helix with syn conformation of dG 
residues. These features cause the repeating unit of Z-form to be 2 base pairs, as opposed 
to a repeating unit of 1 base pair for A- and B-forms. It has the narrowest diameter of all 
3 forms and a severe degree of rotation per base pair (60o versus ~35o for A- and B- 
forms). The three forms and their key structural features are highlighted in Table 2.15, 16  
CD spectroscopy is a powerful tool in elucidating the overall structure of helical 
DNA and RNA. In this type of spectroscopy, the sample is exposed to circularly 
polarized light of varying wavelengths. The circularly polarized light rotates in either a 
clockwise or counter-clockwise direction. Different wavelengths are absorbed by the 
sample, and this absorption also differs depending on the direction of the circularly 
14 
 
Table 2. Structural Parameters of A-, B-, Z-form DNA Configurations. 
Parameter A-form B-form Z-form 
Helix Sense Right-handed Right-handed Left-handed 
Repeating Unit 1 bp 1 bp 2 bp 
Rotation/bp 32.7o 35.9 o 60o/2 
bp/turn 11 10.5 12 
Inclination 19o -1.2o -9o 
Rise 2.3 Å 3.32 Å 3.8 Å 
Pitch 28.2 Å 33.2 Å 45.6 Å 
Propeller Twist 18o 16o 0o 
Glycosyl Angle anti anti 
C: anti 
G: syn 
Sugar Pucker C3′-endo C2′-endo 
C: C2′-endo 
G: C2′-exo 
Diameter 23 Å 20 Å 18 Å 
    
  
  
Figure 9. General CD Spectra of A-, B-, and Z-form DNA configurations. Image taken from 
Springer Images. 
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polarized light. The difference in absorbance between left- and right- polarized light is 
plotted as a function of wavelength to give a unique spectrum specific to the overall 
structure of DNA or RNA, whether it be A-, B-, or Z- form (Figure 9).17 Spectra of the 
same sample can differ as a function of duplex and salt concentrations. The general 
pattern of ellipticity indicates the form of duplex (A-, B-, or Z-). When salt and duplex 
concentrations are held constant, differences in intensity can offer some insight to 
perturbations of the structure. Base-stacking, handedness of the helix, and overall 
disturbances of the helix can be observed in the CD spectra.  
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1.3 Nucleic Acid Thermodynamic Stabilization  
 The different structures of nucleic acids are a direct result of the environment of 
the helix. Increases in salt concentration have demonstrated B- to Z- transitions18 and 
additional hydrogen bonding has shown how identical sequences of RNA or DNA 
preferentially exist in A-19 or B-form20, respectively. These and other factors contributing 
to the stability of helical DNA are partly responsible for the molecules’ longevity and 
ability to pass genetic information. 
 The thermodynamic stability of duplex nucleic acids can be measured using 
thermal denaturation curves (Figure 10). In these types of curves, hybridized DNA (or 
RNA) at low temperature is slowly warmed to higher temperatures while monitoring the  
  
Figure 10. Thermal Denaturation Curves of DNA depicting the relationship between sequence and 
stability. Source: Wikipedia. 
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absorbance (λmax 260 nm). As the duplex is heated, it unwinds to single strands. Single 
stranded DNA has a greater absorbance than duplex DNA due to a hyperchromic effect. 
This effect is the result of multiple aromatic residues stacked upon one another within the 
center of the helix, significantly quenching the total absorbed light per base pair. As the 
helix is denatured, these aromatic resides are more exposed and thus able to absorb more 
light. The temperature at 50% denaturation is considered the melting temperature, or Tm, 
and is reflective of the overall stability of duplex DNA.  
 Three factors that significantly contribute to nucleic acid stability are hydrogen 
bonding, base stacking, and phosphate stabilization. Hydrogen bonding is understood to 
occur specifically between each base pair, which lends to a direct mechanism for 
replication and transcription. Adenosine base pairs with thymidine or uridine through two 
hydrogen bonds: one occurs at the N6-amine on A to the O4-carbonyl on T/U and the 
second occurs within the heterocycles at the N1 and N3 positions of A and T/U, 
respectively. Sequences rich in G-C base pairs have been shown to be more stable than 
sequences rich in A-T base pairs because of the presence of a third hydrogen bond 
(Figure 3). A second indication that hydrogen bonding affects duplex stability is that 
longer sequences of polynucleotides are more stable than shorter sequences due to the 
presence of additional hydrogen bonds. An added effect of longer sequences that leads to 
a higher stability is base stacking. 
 At its core, DNA contains a series of aromatic residues stacked upon one another. 
Base-stacking, or pi-pi stacking, results from interactions of electrons in unhybridized p-
18 
 
orbitals. These orbitals are able to interact in an expected manner on the plane of the 
molecule and also with the pi-orbitals of base pairs above and below the plane of the base 
pair. This effect is not only a type of van der Waals intermolecular force, but also allows 
dipole-dipole interactions of DNA. These effects give a net effect that stabilizes the 
duplex and keeps the structure intact. 
 Hydrogen bonding and base stacking favor the formation of the duplex, but this 
favorability is matched with an opposing force. Each strand of DNA is negatively 
charged and bringing these backbones within proximity of one another results in negative 
charge-charge repulsion. The concentration of cations within the environment is directly 
proportional to the stability of the duplex. Increasing the concentration of salt within 
solution has been shown to give higher melting temperatures, with the effect leveling off 
at approximately 1 M.21 These cations have been shown to closely associate with the 
negative backbone, as well as in regions where the two strands are within their closest 
proximities. Specifically, sequences containing A-tracts (4 or more consecutive A-
residues) have a narrower diameter of the helix than random sequences in the 5’ to 3’ 
direction. These narrow regions have been shown to bind ammonium cations by 15N-
NMR studies.22 If the A-tract is followed by a T-tract, the helix reaches a minimum at the 
ApT step (Figure 11, left). The narrowest region occurs at the fourth consecutive A-
residue and continues until the A-tract ends (Figure 11, middle). If an A-tract is 
preceded by a T-tract, the widest region of the helix in this motif will be the in TpA step 
(Figure 11, right). Minimizing the diameter of the helix brings  
19 
 
  
Figure 11.  Structural Effects of A-tract DNA and Localization of Ammonium Cations (circles).  Left: The 
narrowest region occurs at the ApT step of sequences containing A4T4 tracts. Middle: The diameter of 
the helix reaches its minimum at the 4th consecutive A and continues until an ApX step is reached. 
Right: Sequences containing T4A4 tracts are narrowest at the outer regions. Image taken from 
Reference 22. 
Figure 12. DNA Hydration in the Minor Groove occurs between the N3 of dA and O2 of dT, on the 
opposite strand one base pair displaced. A second layer of water bridges the first layer to offer more 
hydrogen bonding and structural reinforcement. 
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opposing backbones very closely together in the minor groove, forming negatively-
charged electrostatic pockets which bind monovalent cations.  
 Neutral molecules other than ammonium have also been shown to bind to A-tract 
DNA and contribute to the overall stability of the duplex.23-25 In particular, hydration 
within the minor groove of A-T rich DNA offers additional hydrogen bonding and 
structural reinforcement. The first insights into the significance and contribution of water 
binding to duplex DNA was in 1981. The crystal structure of 5’-d(CGCG AATT CGCG) 
revealed many interesting facets of B-form DNA.26, 27 This structure had such an impact 
on nucleic acids research, that it is now commonly referred to as the Dickerson 
dodecamer. Importantly, a specific ordering of water molecules in the minor groove was 
shown (Figure 12). Water molecules hydrogen bond with the N3 of adenine and O2-
carbonyl of thymine on the opposite strand, one base pair displaced to form a primarily 
shell of hydration. A second shell forms through water molecules bridging together the 
first shell.  It is now understood that this hydration pattern can occur in any A-T rich 
sequence because the hydrogen bond acceptor on dA and dT are within the same 
proximity in the minor groove in B-form DNA. The N2-amine on dG residues protrudes 
into the minor groove and sterically blocks hydration effects in G-C rich sequences of B-
form DNA. A-form DNA does not demonstrate this effect since the minor groove is too 
shallow.28  
Minor groove hydration of A-T rich sequences in B-form DNA has been shown to 
contribute 0.7 kcal/mol per base pair.29, 30 This value was obtained by incorporation of 
21 
 
modified dA and dT residues which delete the water’s hydrogen bond acceptors at the N3 
of dA and O2 of dT. Nucleoside analogues can be used to probe the structure and stability 
of duplex DNA and are an important contributor to understanding intermolecular forces 
and their role within the helix. 
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1.4 Nucleoside Analogues 
 Nucleosides are defined as a heterocycle bound to a ribose sugar via a β-
glycosidic bond (R stereochemistry at the C1’ of D-ribose). Adenosine, guanosine, 
cytidine, and thymidine exist in chromosomal DNA, but the cell generates multiple 
nucleoside analogues for different metabolic purposes (Figure 13).32 Inosine, for 
example, is used in RNA. Inosine is capable of wobble base pairing to adenosine, 
thymidine, and cytidine. Incorporation of inosine into tRNA allows the molecule to 
contain the same anti-codon and pair with different codons, thus conserving the cells 
energy in the manufacturing of tRNAs.  
 Analogues can be synthesized de novo by the cell for purposes such as those 
discussed above. Synthetic chemistry has made a plethora of analogues accessible; some 
are inspired by native nucleosides while others demonstrate the creative freedoms 
chemists can take outside of physiological conditions. These analogues can be used  
  
Figure 13. Nucleoside Analogues used found in tRNA. 
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medicinally as antivirals or chemotherapeutics (Figure 14). Chain terminators, such as 
Zidovudine or Zalcitabine, lack the 3′-hydroxyl necessary for addition of sequential 
nucleosides during replication. Other sugar modifications include those seen in Entecavir 
and Cytarabine. Entecavir has been shown to block the active site of viral DNA 
polymerase. Cytaribine is used as a chemotherapeutic, but works in the same principal by 
blocking DNA and RNA polymerases in rapidly dividing cells.  
In the past 40 years, many modified nucleoside analogues have been chemically 
synthesized for laboratory purposes such as fluorescence-mediated binding of molecules 
to nucleic acids, purification, and structure/stability studies. These modifications 
commonly occur on the backbone,32 at the 5’33 or 3’34 terminus, or within the major 
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groove of nucleosides.35 Fluorophores and reporter groups are typically attached to the 
C5-methyl on thymine, the exocyclic amine of cytidine, or either terminus of 
polynucleotides, but they have also been shown to attach to amine and thiol modified 
phosphodiester backbones.36 Stability and structural studies have shed light on the 
evolution of DNA and RNA as well as the limitations and tolerances of the helix within 
certain environments. 
An elegant study by Barry Gold and coworkers used nucleoside analogues to 
demonstrate the importance of small molecule binding in the major groove of DNA and 
serves as important background for the work discussed in this thesis.37 In this study, a 
range of functionality was synthetically introduced into the 7-position of guanosine and 
incorporated into self-complementary oligonucleotides to study their effect on the helix 
(Figure 15). The major findings of this study show the thermodynamic importance of the 
N7-G in binding water and ammonium (Table 3).  
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the major groove. 
25 
 
Table 3. Thermodynamic Effect of Various Substitutions in the Major Groove of Duplex DNA. 
 Sequence 
Tm 
(
o
C)
†
 
∆H, 
kcal/mol 
T∆S,‡ 
 kcal/mol 
∆G, 
 kcal/mol 
1 d(GAGAGCGCTCTC) 48.7 -78.2 -71.3 -6.9 
2 d(GAGAc7GCGCTCTC) 44.7 -56.3 -51.9 -4.4 
3 d(GAGAc7
CH2OH
GCGCTCTC) 47.2 -54.5 -49.9 -4.6 
4 d(GAGAc7
CH2NH3+
GCGCTCTC) 52.0 -92.9 -83.8 -9.1 
5 d(CGCGTTTTCGCG) 68.4 -31.0 -26.6 -4.4 
6 d(CGCc7
CH2NH3+
GTTTTCc7
CH2NH3+
GCG) 65.6 -27.0 23.4 -3.4 
†Conditions: 10 mM Phosphate Buffer (pH 7.0), 10 mM NaCl, 7 uM duplex. ‡Determined at 20 oC. 
 
Upon a single deletion of the N7-G (entry 1), the melting temperature decreased by 4 oC, 
corresponding to 2.5 kcal reduction in the favorability of ∆G. Tethering a hydroxyl 
mimic (entry 2) to this position increased the melting temperature relative to c7G by 2.5 
oC, but had little effect on ∆G. The most interesting effect resulted from incorporation of 
a tethered ammonium into this same position (entry 4). This duplex is more stable than 
those containing native dG as shown by a 3 oC increase in the Tm, which correlates to a 
2.2 kcal of stability in ∆G. However, incorporation of multiple ammonium substituted 
analogues into a self-complementary sequence results in a decreased melting 
temperature, due to the close proximity of each ammonium (entries 5 and 6).  
 The stability effects observed through these substitutions also translated into 
alterations within the structure of the helix. CD spectroscopy of all the substitutions 
showed a general B-form helix (as described in section 1.2). Interestingly, the negative 
intensities of each duplex reflect changes in ∆H (Figure 16). The differences in each 
spectrum are understood to correlate to changes in base stacking effects.  
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Figure 16. CD Spectral Effects of Various Substitutions at the 7-position of G. Entry 1: Squares; Entry 2: 
Triangles, Entry 3: Upside Down Triangles; Entry 4: Circles (see Table 3).37  
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1.4 3-deazapurines: Background and Applications 
 A particular class of modified nucleosides used throughout the studies described 
in this thesis are 3-deazapurine nucleosides. IUPAC nomenclature for this type of 
heterocycle is referred to as imidazo[4.5-c]pyridine, but researchers in this field have 
adopted their own purine numbering system that differs from traditional IUPAC 
numbering (Figure 17).  Both names are used interchangeably, sometimes by the same 
author in the same manuscript; they will be referred to here-on by the purine numbering 
system. It should be understood that 3-deaza-2′-deoxyadenosine (dc3A) refers to 
replacement of the N3 by C-H and any other modifications at this position will be referred 
to as 3-deaza-3-substituted-2′-deoxyadenosine (dxc3A) (Figure 18).  
These modified purine systems are found in nature, particularly 3-
deazaadenosine, both in green leaves of spinach and the cutaneous glands and liver of 
sharks and amphibians.38 While little is known about its biological purpose in these 
organisms, it exhibits anti-inflammatory and anti-viral activity. The biological purposes 
of these molecules should not be undermined, but 3-deazapurines can be used to reveal 
important structural and stabilizing features of the minor groove of DNA. Removal of the 
nitrogen allows tethering of small molecules into the minor groove without creating a 
positively charged heterocycle. These modified nucleosides can be used to gain further 
insight into the minor groove of DNA and is the purpose of this work. 
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Figure 17. Numbering Systems for Purines. Left: Traditional IUPAC System. Right: System Adopted by 
Nucleic Acid Researchers. 
Figure 18. General Structure of 3-deaza-3-substituted-2’-deoxyadenosine. 
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Chapter 2: Development of New Protecting/Directing Groups for Glycosylation 
Reactions in Efforts to Synthesis 3-deaza-3-modified-2′-deoxyadenosine Analogues 
2.1 Chemical Synthesis of Nucleic Acids 
Deep investigation of DNA structure and stability requires the ability to modify 
the structure of a nucleic acid. Some modified nucleic acids exist in nature but in order to 
use these molecules as probes, larger amounts than a cell can produce are necessary. Both 
non-natural and natural nucleoside analogues can be accessed in sufficient quantities 
through organic chemistry. The key step in any nucleoside synthesis is the coupling of a 
heterocycle to a sugar.  Often referred to as a glycosylation, the reaction involves 
coupling a modified heterocycle to a protected sugar. The reaction poses the possibility of 
4 products including stereoisomers of the ribose and regioisomers of the heterocycle 
(Figure 1). The exact procedure of this step varies according to the type of heterocycle  
  
Figure 1. Possible Glycosylation Products as shown with Adenine and 2-deoxyribose. 
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(purine or pyrimidine) and sugar (ribose or 2-deoxyribose). In general, 6-chloropurines 
are activated towards glycosylation by deprotonation, while pyrimidines are first silylated 
and then activated with triflate anions (Scheme 1). Naturally occurring nucleosides are β-
N9 for purines and β-N1 for pyrimidines. Directing reactions towards these products are 
important factors in efficiently synthesizing nucleosides and will be discussed throughout 
this chapter.  
 
 
 
 
 
 
 
 
 
 
Purine glycosylations result in two regioisomeric products: N9 and N7. N7 purine 
nucleosides have shown therapeutic potential,1, 2 but in nature, nucleic acids have N9 
conformation, so this is the desired isomer for these studies. Typical ratios of N9 to N7 
Scheme 1. Activation of Purines and Pyrimidines Towards Glycosylation 
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for purine glycosylations are 5:1,3 but deviate once substitutions to the heterocycle are 
considered. Pyrimidines are directed to the proper N1-glycosidic bond since N3 is 
flanked by 2 electron withdrawing oxygens. 
The chemistry of the glycosylation differs depending on whether ribo- or 
deoxyribo- nucleosides are the target. Standard carbohydrate couplings occur via an SN1 
mechanism. Linkages can be directed to a single diastereomer by a phenomenon referred 
to as “neighboring group effect”. This effect utilizes esters on the 2-hydroxyl to block 
one face of the planar oxonium ion (Scheme 2a).4 Because 2-deoxyribose lacks this 
directing hydroxyl functionality, an SN2 type reaction must take place. Deoxyribose is 
functionalized with a leaving group in the α- position, so inversion ensures the desired β- 
diastereomer is formed (Scheme 2b).  
  
Scheme 2. Glycosylation using a) protected ribose b) protected, α-deoxyribose  
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2.2 Synthetic Targets and Previous Routes 
As discussed in Section 1.4, 3-deazapurine nucleosides are a class of nucleoside 
analogues that possess anti-inflammatory and anti-viral properties. These molecules can 
also function to probe the structure of DNA and how molecules bind to the minor groove. 
Synthetic access to the minor groove poses a challenge and is partly responsible for the 
observation that these analogues have not been used more frequently. In order to 
investigate minor groove binding properties, a series of 3-deaza-3-substituted-2’-
deoxyadenosine analogues were designed (Figure 2). The first, 3-deaza-2’-
deoxyadenosine works to effectively remove hydrogen bonding sites of water molecules 
within the minor groove. In order to observe how small molecules bind to the minor 
  
Figure 2. Modifications of dA utilizing dc3A as a stepping stone for more complex substitutions 
(dmc3A, dhmc3A, damc3A, dtmc
3
A) to study small molecule binding to the minor groove of DNA. 
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 groove, the tethering of hydroxyl group as seen in 3-deaza-3-hydroxymethyl-2’-
deoxyadenosine (dhmc3A) and tethering of an amine as shown in 3-deaza-3-
aminomethyl-2′-deoxyadenosine (damc3A) were designed (Chapter 3). Lastly, in 
conjunction with damc3A, 3-deaza-3-thiomethyl-2′-deoxyadenosine (dtc3A) was designed 
to study site specific labeling with fluorophores in the minor groove (Chapter 4). To 
efficiently quantitate the effects of tethered functional groups, 3-deaza-3-methyl-2′-
deoxyadenosine (dmc3A) was designed to approximate the steric bulk these groups 
introduce into the minor groove of DNA. 
The first example of synthetic 3-deazaadenosine nucleosides in the literature 
comes from May and Townsend in 1973.5, 6 Convergent synthesis of the analogue 
occurred between the coupling of the heterocycle (4,6-dichloro[4.5-c]pyridine) and a 
protected ribose sugar (2,3,5-tri-O-benzoyl-D-ribofuranosyl bromide) (Scheme 3). It was 
2 decades later that the deoxyribose form of 3-deazapurine nucleosides was synthesized 
by Matsuda and Minakawa.7 This synthesis began with 4-carboxamidoimidazole 
nucleosides with formylmethyl or cyanomethyl groups in position 5. Problems with these 
syntheses relate to anomeric and regioisomeric mixtures.  
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Scheme 3. First Convergent Synthesis of Protected dc3A. 
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Most procedures for purine glycosylations to 2-deoxyribose follow an SN2 
coupling of an anionic heterocycle with 3,5-protected, α-chloro sugar. Heterocycles can 
be synthesized to possess desired functionality before glycosylation and will be discussed 
in detail. The synthesis of the sugar begins with 2-D-deoxyribose (Scheme 4).8 The 
anomeric center is first protected as a methyl ether (1), followed by toluoyl protection of 
the 3- and 5-hydroxyls (2). The last step involves displacement of the methyl ether with 
hydrochloric acid to afford the α-chloro isomer as a precipitate. The precipitation step is  
 
 
 
 
 
considered somewhat serendipitous in that it specifically precipitates the desired isomer 
and the undesired isomer remains soluble. This reaction funnels all intermediates to the 
α-chloro anomer since the β-anomer is in equilibrium with starting materials. Other 
protecting groups for the 3- and 5-hydroxyls were used, such as acetyl or benzoyl, but 
only toluoyl protecting groups afforded the desired isomer via precipitation. 
The most widely accepted synthetic route for 3-deaza-2’-deoxyadenosine utilizes 
this sugar and a 6-chloro-3-deazapurine.9-12 Mizuno used 6-chloroimidazo[4.5-c]pyridine 
Scheme 4. Synthesis of 1-a-2-deoxy-3,5-O-p-toluoyl-D-ribosylchloride (3).  
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as the heterocyclic synthon, but 2,6-dichloroimidazo[4.5-c]pyridine was later adopted as 
the norm by Cosstick and coworkers. The electron density of deazapurine systems is 
drastically different than the parent purine system due to replacement of this nitrogen 
with C-H. Particularly, 6-chloro-3-deazapurine nucleosides have a high electron density 
on C6, making nucleophilic displacement with ammonia to afford 3-deazaadenosine 
extremely slow and low yielding. Addition of an electron-withdrawing chlorine in the 2-
position decreases the electron density on C-6 and allows the displacement to take place, 
albeit with less than desirable yields. The 2-chloro substituent can be removed from the 
heterocycle by reduction to generate the target 3-deaza-2’-deoxyadenosine. Initially, we 
followed precedent to synthesize 2,6-dichloro-3-deazapurine.13 The use of a novel 
protecting/directing group for glycosylations required use of 6-chloro-3-deazapurine; that 
synthesis will be discussed in section 2.3. The dichloro-heterocycle is synthesized from 
2,6-dichloropyridine in 28% yield over 8 steps (Scheme 5). Oxidation of the starting  
  
Scheme 5. Synthesis of 2,6-dichloro-3-deazpurine  
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material 4 followed by nitrating conditions resulted in installation of the future N9 
position of the heterocycle 6, which was then reduced with Raney Ni and H2 in a Parr 
shaker to afford 7. Since strong nitrating conditions led only to decomposition, the 
second nitration was performed at 0 oC and then followed with an acid-catalyzed 
rearrangement to install the N7 position (9).  To complete the 3-deazapurine ring system, 
the nitro group is reduced again with Raney Ni and then reacted with triethylorthoformate 
in the presence of acetic anhydride to cyclize the imidazole moiety. Reflux with diluted 
sodium hydroxide followed by neutralization with hydrochloric led to precipitation of 
2,6-dichloro-3-deazapurine (11).  
Synthesis of the methyl-substituted deazapurine begins with 3-picoline-N-oxide 
(Scheme 6, 12).14 Nitration with concentrated H2SO4 and fuming HNO3 gave 13 which 
was followed by reduction of the nitro group and concomitant removal of the N-oxide 
with Raney Ni/H2 in a Parr shaker at 65 psi to give 14. Similar to steps in the synthesis of 
2,6-dichloro-3-deazapurine, a second nitration with external cooling was performed to 
give nitroamine 15, which was followed by sulfuric acid catalyzed rearrangement. 
Contrary to the previous synthesis, this reaction was not reproducible, sometimes 
complete in 8 h and sometimes requiring 48 h or more. The following reduction step was 
also problematic. The reported yield of the reduction-chlorination of 16 to 17 was 29% 
with numerous side products. The optimized conditions used more SnCl2 (4.9 vs. 1.6 
equiv), 5 mL/g of HCl, and reproducibly gave 70% isolated yield without the need for 
chromatography. Finally, cyclization to 18 using triethylorthoformate and acetic  
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anhydride afforded 23 in 96% with purification possible by passing the crude product 
through a silica plug.  
Protected nucleosides of dA, dc3A, and dmc3A were produced by glycosylation 
vivia sodium hydride deprotonation followed by addition of α-chlorosugar 3 (Scheme 7) 
of 6-chloropurine (19) and the 3-deazapurine derivatives (11 and 18). The coupling of 6-
chloropurine 19 and 2,6-dichloro-3-deazapurine 11 resulted in similar yields of the 
desired β-N9 nucleoside (57% and 59%, respectively), but addition of the methyl group 
on the 3-position of 6-chloro-3-deaza-3-methylpurine 18 drastically shifted the product to 
β-N7 (61%). The protected nucleosides (20a, 21a, 21b) are reacted in an enclosed vessel 
with concentrated methanolic ammonia to complete the synthesis of the free nucleosides 
in yields of 71% for dA, 44% for dc3A, and 25% for dmc3A. The overall yield for the  
Scheme 6. Synthesis of 6-chloro-3-deaza-3-methylpurine.  
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synthesis of dA (23) from 6-chloropurine 19 is 41%. It is clear that the 3-deazapurine 
system is less reactive towards nucleophilic displacement as the yield of 24 from 11 is 
26% over two steps. Lastly, the overall yield of the methyl derivative, dmc3A, over two 
steps is 10%, which stems from both introduction of steric bulk into the 3-position during 
glycosylation and poor reactivity of the heterocycle to nucleophilic displacement. The 
methyl group effectively interferes with glycosylation at the N9 of the heterocycle, 
driving the product towards a β-N7 nucleoside. It was clear from these results that the 
introduction of larger substituents in the 3-position necessary for the syntheses of 
hydroxymethyl, aminomethyl, and thiomethyl derivatives would only further decrease the 
yield of β-N9 product from the glycosylation.  
Scheme 7. Formation of dA, dc3A, and dmc3A.  
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2.3 Directing and Protecting Groups for Glycosylation Reactions 
 Glycosylation reactions have commonly been referred to as the “bottle-neck” 
step15 of any nucleoside synthesis due to their less than desirable yields and multiple 
products. In addition, 3-deazapurines require harsh conditions to install the N6-exocyclic 
amine,16 which is reflected in the yield of this step. Our first goal, in collaboration with 
Joseph W. Arico and Amy K. Calhoun, was to install the amine on the heterocycle prior 
to glycosylation, as heterocycles are more stable than nucleosides to robust conditions. 
Our second goal involved design of a protecting group that functions to both protect the 
amine and direct the glycosylation to β-N9 since leaving the exocyclic amine unprotected 
during glycosylation leads to unwanted side reactions with NaH. Our first attempt used 
amide groups to protect the exocyclic amine on 3-deaza-3-methyladenine (Scheme 8). 
Refluxing 6-chloro-3-deaza-3-methylpurine 18 with anhydrous hydrazine, followed by 
Raney Nickel reduction afforded 3-deaza-3-methyladenine 26, which could then be  
  
Scheme 8. Amide protection and formation of 3-deaza-3-methyladenine. 
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protected. Benzoyl and isobutyroyl protecting groups are commonly used on the 
exocyclic amines of nucleoside phosphoramidites as they are easily cleaved in 
concentrated ammonium hydroxide at 55 oC. Reaction of 26 with benzoyl chloride or 
isobutyrl anhydride resulted in amides 27 and 28, respectively. These and unprotected 
amine 26 were subjected to standard glycosylation conditions (Scheme 9), but each 
derivative gave lower yields that the initial reaction with the chloro substituted analogue. 
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About this time, the Robins group published a series of manuscripts detailing the 
use of substituted imidazole and triazole protecting groups that worked to direct the 
glycosylation ratio.17-19 The azoles were installed by treatment of 6-chloropurine in DMF 
and could be removed after the glycosylation to expose the N6-amine. The total yield of 
products from use of 2-propylimidazole as the directing group was 50%, with a 4:1 ratio 
of β-N9 to β-N7 coupling products. The yield of β-N9 products had not improved, but 
the 10% yield of β-N7 has significantly decreased, which should make separation of the 
two isomers easier. Regrettably, no reaction took place upon treatment of the 
deazapurines with 2-propylimidazole, due to the electron-rich properties of 3-
deazapurines. 
The final endeavor involved the use of cyclic imides to protect the amine and 
direct the glycosylation. In general, the cyclic imides could be installed by mixing the 
corresponding anhydride with an aminopurine derivative in the presence of DBU and 
pyridine at reflux for 20 hours (Scheme 10). Trace amounts of amide co-eluted with the 
imide during column chromatography and could be converted by treating the mixture 
with thionyl chloride. The fully cyclized imide could be obtained in approximately 80% 
yield. 
We began our studies with phthalic anhydride 35 as it is commercially available 
and has been used as a protecting group in phosphoramidite chemistry. Glycosylation of 
phthalimide protected 6-aminopurine 38 resulted in 36% β-N9 as the sole product, 
suggesting that this group effectively blocks the N7 position from reacting (Scheme 11).  
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Scheme 11. Glycosylation of Phthalimide Protected Purines  
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Using the 3-deaza-3-methyl protected analogue, the total yield of glycosylation 
was 60% with the ratio of β-N9 to β-N7 as 1:1, indicating that phthalimide cannot 
overcome the sterics presented by the methyl group. In addition, an equal amount of α- 
and β- isomers were produced, leaving only 15% total yield of the desired product. It 
should be noted that the protected sugar should only yield β-anomer coupling products, 
but formation of α-anomer products still occurs. Glycosylation reactions require polar, 
aprotic solvents. Sugars are capable of anomerizing in polar solvents after some time, 
especially with the long coupling times used for this reaction. Shorter coupling times 
have shown to reduce the formation of α-products without much affect on the yield of β-
N9 product, but currently the heterocycles are only soluble in polar solvents so 
anomerization remains problematic. Further study of this protecting group revealed a 
particular lack of stability – it could be effectively removed in 3 M NH3 in methanol in 
under 20 minutes. For some applications, such as post-DNA synthesis deprotection, this 
characteristic may be advantageous, but for our purposes it was not stable enough to use 
as a protecting group to synthesize phosphoramidites. 
We next focused our efforts on the other two potential groups. As aliphatic 
imides, it seemed promising that these tetrahedral protecting groups would serve to block 
the N7-position more effectively than the planar phthalimide group.  Anhydrides 36 and 
37 are not commercially available and therefore must be produced from corresponding 
available materials. Cis-1,4-cyclohexyldicarboxylic acid could be used to obtain 36 after 
treatment with acetic anhydride followed by distillation (Scheme 12).20  
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Tetramethylsuccinyl anhydride 37 was prepared from azobisisobutyronitrile (AIBN) as 
its commercial source. AIBN is typically used in small amounts as an initiator in radical 
chemistry; we were able to take advantage of its ability to fractionate and terminate with 
itself to form intermediate 42 in 72% yield. Treatment of 42 with diluted sulfuric acid 
hydrolyzed the dinitrile to the corresponding di-acid which could then be dehydrated to 
form cyclized anhydride 37.21 With both aliphatic anhydrides on hand, we attempted to 
protect the exocyclic amine on 6-aminopurine and 6-amine-3-deaza-3-methylpurine. 
Cis-1,4-cyclohexyl anhydride 36 proved fruitless in attempts to install the imide 
on the heterocycle, most likely due to its tendency to polymerize at high temperatures, as 
seen in its synthesis. Tetramethylsuccinyl anhydride 37 followed the general protocol 
(Scheme 10) to protect the exocyclic amine. Glycosylation of the protected nucleobases  
Scheme 12. Preparation of Aliphatic Cyclic Anhydrides  
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resulted in the following: tetramethylsuccinyl (M4SI-) adenine resulted in exclusive β-N9 
product in 71% yield, while the protected methyl derivative resulted in 74% β-N9 with 
9% β-N7 (Scheme 13). The results of the glycosylation reactions with chloro-, 
phthalimide, and M4SI- protected  heterocycles are highlighted in Table 1.  
In order to investigate the orientation of M4SI- in respect to the nucleobase, a 
crystal structure of 43 was obtained (Figure 3). Our initial instincts with the cyclic imide 
led us to believe the carbonyls of the protecting group would remain in the plane of the 
nucleobase as to maximize p-orbital electron sharing with the aromatic purine. To our 
surprise, the protecting group was rotated 52o relative to the plane of the heterocycle, 
most likely due to the proximity of the imide oxygen to C5 and N7 of the heterocycle (3.0 
and 3.1 Å, respectively). The methyl groups can be observed positioned “umbrella-like” 
over the N7 position, likely the culprit of this group’s ability to direct the glycosylation to 
Scheme 13. Glycosylation of M4SI-protected Purines  
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β-N9. This also helps explain why phthalimide worked so poorly as a directing group 
with the methyl derivate (Table 1). It appears that larger substitutions on the succinimide 
group might function to completely block formation of β-N7 nucleosides, leading to a 
new class of protecting and directing groups for purine glycosylation.  
  
Figure 3. Crystal Structure of M4SI-protected adenine. a) Face-On View. b) Top-Down View showing 
methyl positioned over N7. 
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Table 1. Glycosylation Results of Various 6-substituted purines 
Heterocycle R β-N9 β-N7 β-N9:β-N7 α-N9/α-N7 
 
19 R = N 57% 13% 4.7 : 1 0% 
18 R = CCH3 39% 69% 1 : 2.2 0% 
      
 
38 R = N 36% 0 >99 : 1 0 
26 R = CCH3 15% 16% 1 : 1.1 31% 
      
 
43 R = N 71% 0% >99 : 1 6% 
44 R = CCH3 74% 9% 8.2 : 1 3% 
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2.4 Next Generation Protecting and Directing Groups 
 As described in the previous section, purine glycosylations have served as a 
laborious step in purine nucleoside synthesis, making it expensive and time consuming. 
Our work with tetramethylsuccinimide (M4SI-) has improved the overall yield of N6-
protected adenosine from 6-chloropurine derivates by as much as 23% (Table 2). 
However, problems still exist with the current synthesis, particularly to syntheses 
involving substitutions at the 3-position of the purine. Separation of unwanted isomers 
produced during the glycosylation requires very long and tedious chromatography 
techniques, including extra long columns, special silicia gel, and multiple columns in 
order to completely isolate β-N9 from β-N7, α-N9, and α-N7 isomers.  
Next generation protecting and directing groups are targeted towards resolving 
these issues by complete blockage of the N7 position and less polar reaction solvents. 
From our results with tetramethylsuccinimide as a protecting and directing group, we 
designed an analogue containing two cyclohexyl groups in place of the four methyls on 
the anhydride in collaboration with Ayan Pal. These cyclohexyl groups serve two 
functions: 1) to increase the steric size of the substitutions on the protecting group as to 
direct glycosylation solely to N9 product and 2) to increase the aliphatic character of the 
heterocycle as to make it more soluble in less polar solvents, such as dichloromethane, 
which should help to prevent α-anomeric products from forming. The synthesis of the 
dicyclohexylsuccinyl anhydride and protection of 6-aminopurine are analogous to that the 
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tetramethylsuccinyl anhydride. Use of this derivative under standard glycosylation shows 
90% yield of β-N9 nucleoside as the sole product. 
Table 2. Comparisons of Total Yield of N
6
-Protected Adenosine Derivatives from corresponding 6-
chloropurines 
 
 
 
 
 
 
 
 
R Pathway A  Pathway B 
N 32% 40% 
CH 17% 31% 
CCH3 8% 31% 
  
  
Scheme 14. Next Generation Protecting Groups. 
53 
 
2.5 Experimental 
General Procedures 
All reactions were carried out under an inert atmosphere with dry solvents under 
anhydrous conditions unless noted otherwise. Dry tetrahydrofuran (THF), diethyl ether 
(Et2O), N,N-dimethylformamide (DMF), pyridine (pyr), acetonitrile (MeCN), and 
dichloromethane (DCM) were obtained by passing commercially available pre-dried, 
oxygen-free formulations  through activated alumina columns. Dry methanol (MeOH) 
was obtained by distillation from Mg(OMe)2. Yields refer to chromatographically and 
spectroscopically (1H NMR) homogeneous materials, unless otherwise stated. Reagents 
were purchased at the highest commercial quality and used without further purification, 
unless otherwise stated. Reactions were monitored by thin-layer chromatography (TLC) 
carried out on 0.25 mm Silicycle TLGR10011B-323 60 Å plates using UV light as 
visualizing agent and sulfuric acid stain and heat as developing agents. Dynamic 
Adsorbents silica gel (60 Å, particle size 32-63 µm) was used for flash column 
chromatography. Difficult separations were carried out using “chromatospec silica gel” 
(E. Merck Chromatospec silica gel (60 Å, particle size 15-40 µm). NMR spectra were 
recorded on Varian VNMRS 400, VNMRS 500, VNMRS 600, or INOVA 500 
instruments and calibrated using residual undeuterated solvent (CDCl3: δ H = 7.26 ppm, δ 
C = 77.16 ppm, acetone-d6: δ H = 2.05 ppm, δ C = 29.84, DMSO-d6: δ H = 2.50 ppm, δ 
C = 39.52 ppm, methanol-d4: δ H = 3.31 ppm, δ C = 49.00 ppm) as an internal reference. 
The following abbreviations are used to designate the multiplicities: s = singlet, d = 
doublet, t = triplet, q = quartet, quin = quintet, m = multiplet, br = broad. High-resolution 
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mass spectra (HRMS) were recorded on a Waters LCT Classic or JEOL AccuTOF mass 
spectrometer using ESI (electrospray ionization) or DART (direct analysis in real time). 
1-α-2-deoxy-3,5-O-p-toluoyl-D-ribosyl chloride (3).4 Acetyl chloride (210 uL, 2.95 
mmol) in MeOH (10 mL) was stirred for 1.5 hr at room temperature under N2 
atmosphere. To the solution was added 2-deoxy-D-ribose (10 g, 74.6 mmol). The solution 
was allowed to stir for 2 hr at room temperature until TLC indicated complete 
consumption of starting material and conversion to 1. AgCO3 was added until the 
solution was neutral and the suspension was filtered through a celite pad. The filtrate was 
evaporated to dryness to give a honey-like oil. To this oil was added DMAP (1.13 g, 9.69 
mmol) and pyridine (80 mL), followed by addition of p-toluoylchloride (20.7 mL, 156 
mmol). After 12 hr at 0 oC, intermediate 2 was diluted with 150 mL of water and 
extracted with diethyl ether (3 x 100 mL). The organic layer was then washed with 
NaHCO3 (5 x 50 mL) and brine (50 mL). The organic layer was collected, dried over 
Na2SO4, filtered, and evaporated to dryness. The final step involves dissolving 2 in 
diethyl ether (20 mL) and cooling to 0 oC. HCl gas is made in situ with NaCl and H2SO4 
in a separate apparatus and then bubbling into the protected sugar solution. After 
approximately 10 min, a precipitate should form. This precipitate is the α-chloro anomer. 
If this is not the case, HCl(g) is bubbled through for an addition 20 minutes. If there is still 
no precipitate, the mixture can be concentrated and then precipitated from concentrated 
solution in CH2Cl2 by slow addition into rapidly stirring Et2O in an ice bath. 1H NMR 
(500 MHz, CDCl3) δ 7.99-7.86 (m, 4H), 7.26-7.20 (m, 4H), 6.45 (d, J = 5.1 Hz, 1H), 5.54 
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(m, 1H), 4.84 (m, 1H), 4.66 (dd, J = 12.1, 9.0 Hz, 1H), 4.57 (dd, J = 12.1, 7.8 Hz, 1H), 
2.85 (m, 1H), 2.73 (d, J = 15.0 Hz, 1H), 2.40 (s, 3H), 2.39 (s, 3H). 
4-Nitro-3-picoline N-oxide (13)14 To a flask containing 3-picoline N-oxide 12 (20 g, 
183 mmol) was slowly added 100 mL of concentrated H2SO4. While keeping the 
temperature below 80 °C, 40 mL of 90% fuming HNO3 was added. The reaction mixture 
was then carefully heated to 100 °C until an exothermic reaction was observed with 
evolution of a brown gas. The flask was removed from heat until the bubbling had 
subsided, then heated at 120 °C for 2 h, after which it was cooled to room temperature 
and poured over 300 g of crushed ice. This mixture was placed in an ice bath and titrated 
with concentrated NH4OH until a yellow precipitate formed at basic pH. The mixture was 
filtered and the solid collected and dried to yield 19.74 g (70%) of 13. This compound 
could be used directly for the next step; recrystallization from methanol yielded 
analytically pure material. 1H NMR (400 MHz, acetone-d6): δ 8.29 (s, 1H), 8.19 (m, 1H), 
8.11 (d, J = 12 Hz, 1H), 2.59 (s, 3H); MS (ESI): m/z 154 (M+). 
4-Amino-3-methylpyridine (14)14 Raney nickel 2800 (8.0 g; CAUTION: pyrophoric; 
weighed under tared volume of water) was added to 100 mL of methanol and pre-reduced 
in a Parr shaker with H2 at 60 psi for 5 min. Compound 13 (8.0 g, 52 mmol) was added 
and reduced at 65 psi for 4 h. The mixture was then filtered through Celite, washed 
thoroughly with methanol and dried in vacuo to obtain 5.34 g (95%) of a slightly green 
solid. Compound 14 is oxidized easily; therefore it was purged with argon and stored at 4 
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°C until used. 1H NMR (400 MHz, acetone-d6): δ 7.96 (s, 1H), 7.94 (d, J = 4.8 Hz, 1H), 
6.55 (d, J = 4.8 Hz, 1H), 5.24 (bs, 2H), 2.08 (s, 3H); MS (ESI): m/z 108 (M+). 
4-Nitramino-3-methylpyridine (15)14 Compound 14 (6.80 g, 63 mmol) was dissolved in 
51 mL of concentrated H2SO4 and cooled to 5 °C in a dry ice/ethanol bath. 70% HNO3 
(21 mL) was added slowly to maintain the reaction temperature below 10 °C. The 
reaction mixture was allowed to stir at 10 °C for 1 h and then poured onto 200 g of 
crushed ice. Concentrated NH4OH was then added until a creamy off-white precipitate 
was formed at pH 7. The mixture was filtered and the precipitate recrystallized from hot 
water to yield 8.11 g (84%) of 15. 1H NMR (400 MHz, DMSO-d6): δ 8.15 (d, 2H), 8.00 
(d, J = 6.6 Hz, 1H), 2.08 (s, 1H); MS (ESI): m/z = 153 (M+). 
3-methyl-5-nitropyridin-4-amine (16)14 Compound 15 (2.00 g, 13 mmol) was added to 
19 mL of concentrated H2SO4 in small portions to avoid decomposition of the starting 
material. The mixture was allowed to stir at room temperature for 18-48 h until complete 
(reaction was monitored by removing aliquot, neutralizing with conc. NH3, filtering, and 
analyzing the precipitate by 1H NMR) and then quenched by pouring over 200 g of 
crushed ice. This mixture was then slowly titrated with concentrated conc. NH3 while 
cooling in an ethanol/dry ice bath. When the mixture reached pH 6.5–7 a yellow 
precipitate formed. This was filtered and dried to yield 1.02 g (54%) of 16. 1H NMR (400 
MHz, DMSO-d6): δ 8.87 (s, 1H), 8.09 (s, 1H), 7.66 (bs, 2H), 2.12 (s, 3H). MS (ESI): m/z 
153 (M+). 
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2-chloro-5-methylpyridine-3,4-diamine (17)14 Anhydrous stannous chloride (12.64 g,  
66.7 mmol,) was added to 51 mL of concentrated HCl followed by 16 (3.4 g, 22 mmol) 
and the reaction mixture heated at 90 °C for 1.5 h. TLC (9:1 DCM:MeOH) of an aliquot 
(pH adjusted to 12 and extracted with EtOAc) showed complete consumption of starting 
material. The reaction mixture was allowed to cool to room temperature and poured over 
475 g of crushed ice. The pH was adjusted to 12 with 7 M NaOH and the reaction 
mixture extracted with EtOAc (4 x 200 mL). The combined organic layers were dried 
with MgSO4, filtered, and dried in vacuo to afford 2.46 g (70%) of white solid. In most 
cases the crude product was pure enough to be used directly in the next step; otherwise, 
flash column chromatography eluting with 9:1 DCM:MeOH gave pure 17. 1H NMR (400 
MHz, DMSO-d6): δ 7.20 (s, 1H), 5.47 (bs, 2H), 4.63 (bs, 2H), 1.95 (s, 3H). MS (ESI): 
m/z 157 (M+). 
4-chloro-7-methyl-1H-imidazo[4,5-c]pyridine (18)14 Under argon atmosphere, 20 mL 
of anhydrous triethylorthoformate (distilled from Na) and 20 mL acetic anhydride 
(fractionally distilled) was added to 4.0 g (25.4 mmol) of 17 and refluxed for 1 h. The 
reaction was cooled to room temperature and dried in vacuo. The crude compound is 
boiled in 10% NaOH (10 mL) for 15 minutes and then cooled. Neutralization with HCl 
precipitates 3.61 g of 18 in 85% yield.  1H NMR (400 MHz, DMSO-d6): δ 13.3 (bs, 1H) 
8.45 (s, 1H), 7.91 (s, 1H), 2.44 (s, 3H). MS (ESI): m/z 167 (M+). 
7-methyl-1H-imidazo[4,5-c]pyridin-4-amine (26).12 To a flask containing 18 (1.50 g, 
7.49 mmol) under nitrogen was added 25 mL of anhydrous hydrazine. The mixture was 
heated to reflux for 30 h. The hydrazine was removed in vacuo and co-evaporated with 
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EtOH (3 x 15 mL). Water (45 mL) and Raney nickel (2.25 g, CAUTION: pyrophoric, 
weighed under tared volume of water) were added and the mixture heated to reflux with 
vigorous stirring to prevent the Raney Ni from sticking to the stir bar. After 1 h the 
mixture was filtered, while still hot, through a pad of Celite and the pad washed with hot 
water (200 mL, CAUTION: prevent leftover Raney Ni from drying). Evaporation of the 
filtrate in vacuo afforded a brown solid. This was re-dissolved in MeOH and silica gel 
was added. After thorough drying of the mixture the resulting fine powder was loaded 
onto a flash column and purified by elution with 9:1 DCM:MeOH containing 0.7 M NH3 
to obtain 26 as a white amorphous powder (965 mg, 87%) and starting material (400 mg, 
13%). Repetition of this procedure gave yields varying between 60–87%. 26: Rf = 0.22 
(silica gel, 9:1 DCM:MeOH with 0.7 M NH3); 1H NMR (DMSO-d6, 400 MHz) δ 12.55 
(brs, 1H), 8.08 (s, 1H), 7.42 (s, 1H), 5.86 (brs, 2H), 2.26 (s, 3H) ppm; 13C NMR (DMSO-
d6, 101 MHz) δ 150.79, 140.69, 139.39, 126.57, 108.00, 14.55 ppm; HRMS (DART-
TOF) calcd for C7H9N4H+ [M + H]+ 149.0827, found: 149.0834. 
General Method for Di-imide Protections 
 To a flask containing a 6-aminopurine derivative (adenine or 26, 4.38 mmol) and 
anhydride (2 eq, 8.77 mmol) was added pyridine (45 mL) and DBU (3 eq, 13.16 mmol). 
The mixture was heated to reflux for 18 h. Volatiles were removed in vacuo and the 
residue co-evaporated with toluene (3 x 10 mL) to remove residual pyridine. The 
resulting brown oil was purified by flash column chromatography eluting with 95:5 
DCM:MeOH to obtain 1.14 g of white solid. The solid was thoroughly dried in vacuo and 
treated with 10 mL of SOCl2 at reflux for 2 h with a drying tube attached. Volatiles were 
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removed in vacuo; coevaporation with EtOAc (3 x 10 mL) was used to remove residual 
SOCl2. The resulting off-white solid was then purified by flash column chromatography 
eluting with 95:5 DCM:MeOH to obtain the di-imide compound as a white amorphous 
powder. 
43: Rf = 0.61 (silica gel, 9:1 DCM:MeOH); 1H NMR (DMSO-d6, 500 MHz) δ 13.88 (brs, 
1H), 8.95 (s, 1H), 8.68 (s, 12 1H), 1.28 (s, 12H) ppm; 13C NMR (DMSO-d6, 101 MHz) δ 
181.18, 152.82, 147.98, 48.60, 21.93 ppm; HRMS (DART-TOF) calcd for C13H15N5O2H+ 
[M + H]+ 274.1297, found: 274.1304. 
44: Rf = 0.29 (silica gel, 95:5 DCM:MeOH); 1H NMR (acetone-d6, 400 MHz) δ 8.27 (s, 
1H), 8.12 (s, 1H), 2.57 (s, 3H), 1.33 (s, 12H); 13C NMR (acetone-d6, 101 MHz) δ 182.63, 
145.10, 142.18, 49.06, 22.47, 14.94; HRMS (DART-TOF) calcd for C15H19N4O2H+ [M + 
H]+ 287.1508, found: 287.1508. 
 
General Method for Glycosylation Reactions 
 To a flask containing the desired heterocycle and NaH (1.5 eq) was added MeCN 
(final concentration of heterocycle = 0.05 M). The mixture was allowed to stir for 0.5 h 
followed by addition of α-chlorosugar 3 (1.8 eq). The reaction stirred for 2-8 hr, after 
which the reaction mixture was filtered through a celite pad. Volatiles were removed in 
vacuo and the resulting crude product was purified by flash chromatography. M4SI - 
derivatives can be purified with 1:1 Hex:EtOAc to afford  the glycosylated product as a 
white foam. Products obtained by using Cy2SI required 2:1 Hex:EtOAc as the eluent for 
chromatography.  
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45a: Rf = 0.33 (silica gel, 97:3 DCM:MeOH); 1H NMR (acetone-d6, 400 MHz) δ 8.88 (s, 
1H), 8.69 (s, 1H), 8.01 (d, J = 8.2 Hz, 2H), 7.92 (d, J = 8.1 Hz, 2H), 7.36 (d, J = 7.9 Hz, 
2H), 7.29 (d, J = 8.6 Hz, 2H), 6.79 (dd, J = 7.9, 6.1 Hz, 1H), 6.03 – 5.91 (m, 1H), 4.85 – 
4.62 (m, 3H), 3.57 (ddd, J = 14.4, 7.9, 6.5 Hz, 1H), 2.99 (ddd, J = 14.3, 6.1, 2.6 Hz, 1H), 
2.42 (s, 3H), 2.39 (s, 3H), 1.35 (s, 12H) ppm; 13C NMR (acetone-d6, 101 MHz) δ 181.25, 
166.95, 166.77, 154.65, 153.38, 147.36, 146.48, 145.52, 145.16, 132.35, 130.93, 130.80, 
130.49, 130.44, 128.49, 128.34, 86.67, 84.06, 76.38, 65.21, 49.29, 37.61, 22.00, 21.96, 
21.88, 21.87 ppm; HRMS (ESI-TOF) calcd for C34H35N5O7Na+ [M + Na]+ 648.2445, 
found: 648.2417. 
46a: Rf = 0.35 (silica gel, 97:3 DCM:MeOH); 1H NMR (acetone-d6, 600 MHz) δ 8.56 (s, 
1H), 8.13 (d, J = 0.9 Hz, 1H), 8.05 – 7.96 (m, 2H), 7.93 – 7.83 (m, 2H), 7.40 – 7.33 (m, 
2H), 7.33 – 7.24 (m, 2H), 6.90 (dd, J = 7.8, 5.8 Hz, 1H), 5.86 (dt, J = 6.3, 3.1 Hz, 1H), 
4.76 (td, J = 4.7, 3.2 Hz, 1H), 4.71 – 4.60 (m, 2H), 3.26 (ddd, J = 14.4, 7.8, 6.7 Hz, 1H), 
3.09 (ddd, J = 14.3, 5.8, 3.0 Hz, 1H), 2.81 (s, 3H), 2.43 (s, 3H), 2.39 (s, 3H), 1.33 (d, J = 
32.6 Hz, 12H) ppm; 13C NMR (acetone-d6, 151 MHz) δ 181.76, 166.50, 166.36, 145.18, 
144.78, 143.51, 143.49, 140.30, 138.59, 138.34, 130.55, 130.38, 130.13, 130.11, 27.99, 
127.91, 119.95, 86.26, 83.39, 75.55, 64.81, 48.39, 38.59, 21.93, 21.72, 21.61, 21.57, 
21.44, 15.51 ppm; HRMS (ESI-TOF) calcd for C36H38N4O7Na+ [M + Na]+ 661.2638, 
found: 661.2629. 
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ABSTRACT
Tetramethylsuccinic anhydride can be used to protect the exocyclic amine of 6-aminopurine derivatives by forming the corresponding
tetramethysuccinimide. X-ray crystallography confirms that the imide carbonyl and the methyl groups are positioned to sterically block the N7
nitrogen so that glycosylations occur with very high regiochemical control at N9. This approach is particularly effective for 3-substituted
purines where the substituent tends to block access to N9 and inhibit glycosylation at that site.
Syntheses of purine 2′-deoxynucleosides are challenging,
particularly because the glycosylation step must be both
regioselective and diasterioselective. Reaction yields of the
naturally occurring -N9 products are often low to moderate.
Most preparations of purine 2′-deoxynucleosides employ the
sodium salt method,1 which typically uses a 6-chloropurine
heterocycle and 2-deoxy-3,5-di-O-(p-toluoyl)-R-D-erythro-
pentofuranosyl chloride.2,3 For example 6-chloropurine (1a,
Table 1) reacts to form 57% -N9 nucleoside and 13% -N7
with no R-isomers detected.1 Treatment with NH3/MeOH
deprotects the sugar and displaces the 6-chlorine to form 2′-
deoxyadenosine. Small changes in the sterics or electronics
of the heterocycle can impact the ratio of coupling products.
The favorable coupling ratio for 1a (N9:N7 ) 4.7:1) largely
reverses itself for the 6-chloropurine derivative 2a containing
a 3-deaza-3-methyl substituent (N9:N7 ) 1.0:2.2).4 The
products of 1a and 2a can be separated by flash chroma-
tography, but this is not always the case. Many substrates
produce significant amounts of R-nucleoside products, further
complicating purification and lowering yields.
Robins has described the use of purines bearing a
2-alkylimidazole5,6 or triazole6 in the 6-position to achieve
highly regio- and diastereoselective glycosylations using the
sodium salt method. However, the purine coupling partners
must be prepared from the corresponding oxopurines or the
often expensive chloropurines. In addition, removal of the
2-alkylimidazole was reported to be difficult with most
purines.6 Related studies include the regioselective N9
arylation of purines.7
We attempted to use the Robins method in our work with
2a and other 3-deaza-3-substituted purines, but the 6-(2-
alkylimidazolyl) derivatives of 2a and 3a could not be
prepared, largely because displacement of the 6-chlorine of
3-deazapurines requires harsh conditions (i.e., refluxing
(1) Kazimierczuk, Z.; Cottam, H. B.; Revankar, G. R.; Robins, R. K.
J. Am. Chem. Soc. 1984, 106, 6379–6382.
(2) Rolland, V.; Kotera, M.; Lhomme, J. Synth. Commun. 1997, 27,
3505–3511.
(3) Hoffer, M. Chem. Ber. 1960, 93, 2777–2780.
(4) Irani, R. J.; Santalucia, J. Nucleosides, Nucleotides Nucleic Acids
2002, 21, 737–751.
(5) Zhong, M.; Nowak, I.; Cannon, J. F.; Robins, M. J. J. Org. Chem.
2006, 71, 4216–4221.
(6) Zhong, M.; Nowak, I.; Robins, M. J. J. Org. Chem. 2006, 71, 7773–
7779.
(7) Bakkestuen, A. K.; Gundersen, L. L. Tetrahedron Lett. 2003, 3359–
3362.
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hydrazine followed by Raney nickel reduction4,8 ). Further-
more, the glycosylation products of 3a could not be separated
easily, leading us to seek an alternative procedure.
Here we describe 2,2,3,3-tetramethylsuccinimide (M4SI)
as a new directing/protecting group for the synthesis of -N9
nucleosides with high regio- and diastereoselectivity.
We reasoned that 6-aminopurines protected with a cyclic
imide might perform well as glycosylation partners. The
cyclic imide would (i) protect the amino group from side
reactions, (ii) permit direct glycosylation to N9, and (iii) be
removed by mild base to expose the amino group, with or
without deprotection of the sugar, as needed. We first
examined phthaloyl protection of adenine using phthalic
anhydride. Phthalimide has been reported as a protecting
group in DNA synthesis9,10 and 15N-phthalimide has been
used for the introduction of isotopic nitrogen into nucleo-
sides.11,12 The N6-phthalimide derivative of adenine could
be prepared (1b), although the yield was poor (∼40%) under
all conditions examined. It participated in glycosylation
reactions to give almost exclusively the N9 regioisomer but
in only 36% isolated yield. Deprotection with NH3/MeOH
removed the phthalimide in less than 15 min and the sugar
toluoyl esters after several hours at room temperature. The
amine could be reprotected as needed for DNA synthesis,
but that approach was less than ideal.
We then considered aliphatic anhydrides that might exhibit
better hydrolytic stability, beginning with 1,4-cis-cyclohex-
anedicarboxylic anhydride.13 Unfortunately this compound
polymerizes easily and attempts to prepare simple imides
from ammonia or methyl amine have failed. Attempts to
prepare the cyclic imide from adenine in this work also failed.
The third compound we considered was tetramethylsuc-
cinic anhydride (M4SA). Upon formation of the imide with
adenine (Figure 1) the methyl groups should partially shield
the N7 nitrogen from glycosylation. The cyclic anhydride
M4SA is readily obtained in two steps14 from AIBN.
M4SA reacted smoothly with adenine and other purines
in refluxing pyridine in the presence of DBU (Scheme 1).
Surprisingly, no reaction took place without base, and other
bases such as triethylamine and proton sponge failed to
promote the reaction. A small amount of the amide was
always present due to incomplete cyclization, but this could
be converted to the cyclic imide with refluxing SOCl2,
resulting in 78-81% yields of the purine-N6-tetramethyl-
succinimide. It is important to convert the residual amide
(8) Itoh, T.; Yamaguchi, T.; Mizuo, Y. J. Carbohydr., Nuleosides,
Nucleotides 1981, 8, 119–129.
(9) Kume, A.; Sekine, M.; Hata, T. Tetrahedron Lett. 1982, 23, 4365–
4368.
(10) Beier, M.; Pfleiderer, W. HelV. Chim. Acta 1999, 82, 633–644.
(11) Kamaike, K.; Kinoshita, K.; Niwa, K.; Hirose, K.; Suzuki, K.;
Ishido, Y. Nucleosides, Nucleotides Nucleic Acids 2001, 20, 59–75.
(12) Kamaike, K.; Takahashi, M.; Utsugi, K.; Tomizuka, K.; Ishido, Y.
Tetrahedron Lett. 1995, 36, 91–94.
(13) Hall, H. K., Jr. J. Am. Chem. Soc. 1958, 80, 6412–6420.
(14) Whitesides, G. M.; Hackett, M.; Brainard, R. L.; Lavalleye,
J. P. P. M.; Sowinski, A. F.; Izumi, A. N.; Moore, S. S.; Brown, D. W.;
Staudt, E. M. Organometallics 1985, 4, 1819–1830.
Table 1. Regioselective Purine Glycosylations
a See ref 1. b Unpublished results. c A procedure with KOH and
cryptand catalyst TDA-14 was used instead of the sodium salt method.
d See ref 4.
Figure 1. Structure of adenyl-N6-tetramethylsuccinimide from X-ray
diffraction methods: (a) face view and (b) edge view.
Scheme 1. Synthesis of M4SI-Protected Purines
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into the cyclic imide since the amide (Scheme 1) does not
function well as a blocking group. We obtained the structure
of the M4SI of adenine by X-ray crystallography and two
views are shown in Figure 1. In the “face view” (Figure 1a)
the four methyl groups can be observed positioned “umbrella-
like” above the N7 edge of the adenine ring system. The
distance between the imide carbonyl oxygen and the N7
nitrogen is 3.1 Å, and that to C5 is 3.0 Å. These distances
likely prevent a coplanar conformation between the imide
and heterocycle, and in combination with the four methyl
groups seem sufficient to limit access to N7 by the gylco-
sylation reagent. The “edge view” (Figure 1b) illustrates that
the plane of the imide functionality is in fact rotated 52°
relative to the plane of the heterocycle, and this rotation is
necessary to prevent the steric clash between the imide
carbonyls and the N7 nitrogen and C5 carbon.
We next examined a number of adenine-based heterocycles
for their ability to undergo glycosylation with M4SI as a
directing/protecting group at the 6-position (Scheme 2) and
compared these results with those obtained for the corre-
sponding 6-chloropurine, when available (Table 1). Phthal-
imide-protected heterocycles 1b, 2b, and 3b showed a better
directing efffect for N9 than did the 6-Cl derivatives, but
only gave low to moderate yields; varying and poorly
reproducible amounts of R-nucleosides were always isolated
as well. The N7 and N9 regioisomers could be separated
but the R and  diasteriosomers could not.
In contrast, glycosylation of M4SI-protected adenine 1c
yielded only the N9 isomer. The best yield (71%) was
obtained with phase transfer conditions using KOH/TDA-
115 in comparison with NaH (54%). M4SI performed well
with 3-deaza-3-substituted purines. 2c gave a 6.4:1 ratio of
N9 to N7 -nucleosides, and this ratio increased to 7.59:1
for a 3-deaza analogue bearing a silyl-protected linker (4a).
Although some coupling reactions generated small amounts
of the unwanted regioisomer or diastereomers, with the M4SI
group in place the desired -N9 products could be resolved
from the -N7 and R-nucleosides by flash chromatography.
The R-nucleosides result from anomerization of the chloro-
sugar (structure illustrated in Scheme 2), which is accelerated
in polar solvents.16 While the M4SI group is quite effective
in blocking access to N7, the 3-substituted purines such as
2c and 4a are more hindered nucleophiles; the reaction is
then slower to reach completion and larger amounts of
R-nucleosides are formed.
The M4SI group displayed the desired stability that
phthalimide lacked. Treatment of the coupling products of
1c and 2c with NaOMe/MeOH or 7 M NH3/MeOH at room
temperature removed the two toluoyl esters on the sugar but
not the M4SI (64% and 82% yield, respectively), and in 86%
yield for the coupling product of 4a (see the Supporting
Information).
Purine nucleosides with substituents at the 3-position are
valuable to probe hydration effects in the DNA minor groove.
Even a simple methyl substituent at C3 will be directed into
the minor groove of duplex DNA where it may disrupt or
effect a reorganization of water structure.
As a further example of this protecting group’s utility we
elaborated M4SI-protected 2′-deoxy-3-deaza-3-methyladeno-
sine, the coupling product of 2c, to the DMT-protected
phosphoramidite for use in DNA solid-phase synthesis (see
the Supporting Information). The M4SI can be cleanly
removed with NH3/MeOH or concd NH4OH at 55 °C
overnight, both compatible with DNA synthesis protocols.
The use of M4SI-protected phosphoramidites in solid-phase
DNA synthesis will be reported elsewhere.
M4SI is a valuable new directing/protecting group that
allows rapid access to -N9 6-aminopurine-2′-deoxynucleo-
sides and functions as an effective base-labile protecting
group. It is especially valuable for 3-substituted purines. It
should also serve in other applications where bidentate amine
protection is desired.
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Chapter 3: Use of Tetramethylsuccinimide to Study Effects of Small Molecule 
Binding in the Minor Groove 
3.1 Chemical Synthesis of Modified DNA Oligomers 
 Our primary goal involved tethering hydroxyl and ammonium functionality off 
the 3-position of dA. Synthetic access to minor groove modifications is a requirement in 
order to study how small molecules, such as water and ammonium, bind and associate 
within the minor groove of DNA (Figure 1). Somewhat strenuous conditions (i. e. high 
temperature) are required to functionalize the benzyl position of 3-deaza-3-methylpurine. 
Nucleosides are more sensitive to these types of conditions and have tendencies to 
decompose through depurination at higher temperatures compared to their  
  
Figure 1. Modifications of dA used to study small molecule binding in the minor groove 
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nucleobase predecessors. Therefore, it is more desirable to functionalize the heterocycle 
prior to glycosylation which implies the steric size of the 3-position will only further 
increase (Scheme 1). Tetramethylsuccinimide has served as a valuable tool to direct the 
glycosylation reaction to desired β-N9 products in the presence of steric hinderance at the 
3-position. Using this protecting group will allow us to synthesize minor groove modified 
nucleosides in more acceptable yields. The modified nucleosides can then be deprotected 
and further functionalized to the corresponding phosphoramidites. 
 
  
 
 
Phosphoramidites are the standard building block of chemical, solid-phase DNA 
synthesis.1 Solid-phase DNA synthesis elongates in a 3’ to 5- direction (Figure 2).  The 
5’-hydroxyl on the sugar is protected with dimethoxyltrityl. This group is highly sensitive 
to acid and can be removed using 3% dichloroacetic acid in dichloromethane. Attached to 
the 3’-hydroxyl is a phosphite group functionalized with diisopropylamino and 2-
cyanoethoxy groups. Diisopropylamino groups can be activated within the course of the 
synthesis with tetrazole for displacement by incoming 5’-deprotected phosphoramidites. 
The new linkage is then oxidized with iodine and water in pyridine to prevent further 
reactivity of  
O
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OTol
N
NM4SI
N
N
R
N
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N
N
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H
Scheme 1. Retrosynthesis of 3-substituted 2’-deoxyadenosine Analogues. 
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the phosphite during synthesis. The 2-cyanoethoxy group and heterocycle protecting 
groups can be deprotected post-synthesis with ammonium hydroxide at 55 oC.  
 The oligomer used in these studies contains a central core of 4 dA residues 
flanked by G:C base pairs. This sequence was designed to exhibit small molecule binding 
operties of A-tract DNA. The non-self complementary nature of this sequence allows the 
effects of a single or multiple modifications to be measured. 
 
Figure 2. The DNA solid-phase synthesis cycle using the phosphoramidite method. Source: Wikimedia 
Commons. 
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3.2 Synthesis of dc3A, dmc3A, dhmc3A, and damc3A Phosphoramidites 
 We began with elaboration of dc3A. The use of M4SI- as a protecting/directing 
group eliminated the need for the chloro-substitution at the 2-position of the heterocycle, 
so a new synthesis to obtain the c3A heterocycle was designed. Using 4-hydroxypyridine 
(1) as the starting material, M4SI-protected 3-deazaadenine 8 was synthesized in 7 steps 
(Scheme 2). The synthesis commences with nitration of 1 to install the N7 nitrogen of 
c3A. Conversion of the hydroxypyridine 2 to ethyl ether 3 is accomplished by first 
treating 2 with PCl5 followed by absolute ethanol. This activates the 4-position towards 
displacement with NH4OAc to install the N9 nitrogen (4). The following steps are 
analogous to the synthesis of mc3A as shown in Section 2.2. Treatment with SnCl2 in HCl 
reduces the nitro group and installs chloro-functionality at the 6-position to give 5. The  
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Scheme 2. Sythesis of M4SI-protected 3-deazaadenine (8). 
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imidazole ring is closed using triethylorthoformate and acetic anhydride to give 6, 
followed by displacement of the chlorine with hydrazine and Raney Nickel reduction 
yields 53% of c3A heterocycle 7. The exocyclic amine can be treated with 
tetramethylsuccinyl anhydride in the presence of DBU to produce the functionalized 
heterocycle for glycosylation (8). 
  To further functionalize the 3-position, 3-deaza-3-methylpurine undergoes 
benzyllic bromination after t-Boc protection of the heterocycle. This intermediate is a 
branching point for further elaboration of the 3-position (Scheme 3). The tethered 
hydroxyl is first installed by displacement of the bromide substituted heterocycle with 
sodium acetate in DMF at slightly elevated temperatures. The elevation in temperature in 
a polar solvent is enough to cleave the Boc group from the imidazole moiety, which is 
surprising since this protecting group is most commonly removed with 1:1 TFA:CH2Cl2.  
  Scheme 3. Functionalization of M4SI-mc3A to Install Tethered Small Molecules. 
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12
13
Br
c
d
68 
 
The free hydroxyl results from acetate deprotection with ammonia in methanol. The 
hydroxyl must be protected prior to glycosylation to prevent side reactions with sodium 
hydride.  Amine functionality is first installed by displacement of the bromide with 
sodium azide at elevated temperatures. This serves to prevent the free amine from side 
reactions during glycosylation. The azide can be reduced and selectively protected after 
glycosylation.  
 
 
 
 
 
 
The four M4SI- protected heterocycles (8, 9, 12, and 13) are next glycosylated to 
provide the modified nucleosides (Scheme 4). The c3A-protected nucleoside produces β-
N9 isomer exclusively, much like M4SI-protected adenine, due to the absence of steric 
bulk at the 3-position. Much to our satisfaction, addition of bulkier substitutions off the 3-
position did little to shift the ratio of glycosylation products. This proves the ability of 
M4SI- to direct the glycosylation and yield β-N9 products in approximately 70% yield, as 
opposed to the 20-50% glycosylation yields that were considered acceptable before our 
work.  
Scheme 4. Glycosylation of 3-Modified Adenine Analogues Using M4SI- as a directing group 
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Once the protected nucleosides of dc3A (14a), dmc3A (14b), and dhmc3A (14c) 
are isolated, steps to the phosphoramidites 18a-c are straight-forward (Scheme 5). First, 
the sugar is deprotected with 7 N ammonia in methanol over 10 hr.  Then, the 5’-
hydroxyl can be selectively protected with dimethoxytrityl ether functionality. The 
advantage of using dimethoxytrityl as a protecting group is two-fold: the tertiary 
substituted, large protecting group selectively protects primary hydroxyls over secondary 
hydroxyls and it is extremely labile towards acid leading to complete and effective 
deprotection during oligomer synthesis. Lastly, the phosphite group is installed on the 3’-
hydroxyl. Two common reagents for this step are 2-cyanoethyl N,N,N,N-tetraisopropyl 
phosphane and chloro-2-cyanoethyl-N,N-diisoproylphosphane. They can be used 
interchangeably as they simply differ in how they are activated. 
Scheme 5. Synthesis of dc3A (17a), dmc3A (17b), and dhmc3A (17c) Phosphoramidites 
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The aminomethyl (damc3A) phosphoramidite requires additional steps to 
completely functionalize and protect it for DNA synthesis (Scheme 6). After 
glycosylation, the azide is reduced with 10% palladium on charcoal (20% w/w) and 
hydrogen to afford free amine 18. Deprotection of the toluoyl results in M4SI-protected 
damc3A 19. The amine can be selectively protected over the hydroxyl functionality using 
Fmoc-Cl in dioxane with 10% NaHCO3 (20). Next, the 5’-hydroxyl is protected to give 
the DMT-protected nucleoside 21. To complete the synthesis of damc3A 
phosphoramidite 22, 21 is phosphitylated using standard conditions. 
  
Scheme 6. Synthesis of damc3A Phosphoramidite 22. 
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3.3 Impact of Structural Water Mimic in the Minor Groove 
Using the modified phosphoramidites, DNA of varying sequence and 
functionality can be synthesized. We prepared four types of oligonucleotides: (i) those 
containing 3-deazaadenine, (ii) those containing 3-deaza-3-methyladenine, (iii) those 
containing 3-deaza-3-hydroxymethyladenine, and (iv) those containing 3-deaza-3-
aminomethyladenine. The design parameters were as follows: The first modified oligos 
did not contain the N3 nitrogen, a site that is used in the formation of the spine of 
hydration but otherwise introduces no unfavorable steric effects. In the methyl-containing 
sequences, the N3 nitrogen was also removed, and additional unfavorable steric effects 
were introduced into the minor groove through the presence of one or more methyl 
groups. Third, hydroxyls were introduced onto the methyls to generate a covalently 
bound water mimic capable of interacting by hydrogen bonding in the minor groove. 
Lastly, amines were covalently tethered onto the methyl groups to serve as both an amine 
hydrogen bond donor or ammonium cation depending on the pH of the solution. 
 Thermodynamic parameters were obtained for the formation of all duplexes using 
their melting curves at 5 uM duplex concentration in 20 mM phosphate buffer, pH 7 and 
1 M NaCl (Table 1). Even the simple elimination of a single N3 nitrogen from a centrally 
located dA residue (duplex 2) resulted in a 2.4 °C decrease in the melting temperature 
(TM), consistent with previous reports. In that same study, the introduction of three dA 
residues lacking the N3 nitrogen resulted in a 12 °C change in TM, which also compares 
favorably with the 12.3 °C reduction in TM observed here with four deazaadenines  
72 
 
Table 1. Thermodynamic Stabilities of Duplexes Containing dA Analogues 
Entry 
Core Sequence 
d(CCGG XXXX CGCC) 
Tm
†
 
∆H 
kcal/mol 
∆S 
Cal/molK 
∆G‡ 
kcal/mol 
1 AAAA 63.4 -95.1 (± 4.8) -255 (± 15) -19.1 (± 0.6) 
2 AAA
H
A 61.0 -82.0 (± 5.8) -220 (± 18) -16.4 (± 0.4) 
3 AAA
CH3
A 58.3 -70.8 (± 3.7) -188 (± 12) -14.8 (± 0.3) 
4 AAA
CH2OH
A 60.9 -71.7 (± 3.9) -185 (± 11) -16.4 (± 2.3) 
5 AAA
CH2NH3+
A 62.9 -73.1 (± 1.6) -191 (± 4.6) -17.5 (± 1.1) 
6 (A
H
)4 51.1 -76.1 (± 2.9) -209 (± 9.0) -13.9 (± 0.2) 
7 (A
CH3
)4 44.4 -51.7 (± 4.1) -137 (± 13) -10.8 (± 0.4) 
8 (A
CH2OH
)4 54.7 -82.0 (± 5.5) -224 (± 16) -15.2 (± 0.7) 
9 
(A
CH2NH3+
)4 
44.0 -50.1 (± 6.9) -131 (± 22) -11.1 (± 0.4) 
9* 
(A
CH2NH2
)4, pH 9 
50.4 -38.6 (± 1.2) -93.2 (3.2) -10.8 (± 0.3) 
10 
A
CH2NH3+
AA
CH2NH3+
A 
61.1 -78.6 (± 2.9) -212 (± 7.0) -15.6 (± 1.2) 
†
Determined at 5 uM duplex concentration in 20 mM phosphate buffer, pH 7 (unless otherwise noted) 
and 1M NaCl. 
‡
 Calculated at 298 K.  
 
present (duplex 6). We then examined the methyl-substituted sequences (duplexes 3 and 
7). The 3-deaza-3-methyl analogues both lack the N3 nitrogen but also add steric bulk 
within the minor groove. Introduction of a single methyl group (duplex 3) reduced the TM 
value by 2.7 °C relative to a sequence containing a single 3-deaza analogue (duplex 2) 
and by 5.1 °C relative to the unmodified standard. The presence of four analogues 
containing methyls (duplex 7) reduced the TM by a dramatic 19.0 °C, attesting to the 
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duplex instability resulting from increased steric effects in the minor groove. The 
hydroxymethyl and aminomethyl groups are sterically even larger than a methyl group 
and could have an even more dramatic destabilizing effect should these groups be unable 
to take part in advantageous interactions in the minor groove. Introduction of one 
−CH2OH group did result in helix destabilization relative to the control sequence 
(compare the TM for duplex 4 with that for duplex 1). However, relative to the single-
methyl sequence (duplex 3), the TM for the hydroxymethyl sequence was some 2.6 °C 
higher. This observation is further supported by the sequence with four −CH2OH groups 
(duplex 7), which exhibited a TM 10.3 °C higher than that for the sequence containing 
four methyl groups. The addition of one –CH2NH3+ (duplex 5) resulted in greater 
stabilization relative to methyl and hydroxymethyl (duplex 3 and 4, respectively). The  
single tethering of the ammonium offers near native stability. Direct comparison of the 
two alpha plots shows that the TM values of the two complexes are within error (Figure 
3). 
Substitution with 4 aminomethyl derivatives (duplex 9) at pH 7 was similar in 
respect to the 4 methyl substitutions (duplex 7) differing by 0.4 oC. Four consecutive 
amines function to stabilize the helix more than the ammoniums. Duplex 9* has a TM of 
50.4 oC, which appears more similar to the hydroxymethyl substituted duplex 7, 
suggesting it is acting as a hydrogen bond donor, albeit a somewhat weaker donation than 
that of the hydroxyl groups. We concluded that 4 consecutive ammonium cations (duplex 
9) results in charge-charge repulsion within the minor groove. Duplex 10 was designed to 
indicate whether the presence of multiple groups leads to a more stable duplex than  
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native, since a single substitution has a stabilizing effect while consecutive substitutions 
lead to an overall destabilization of the helix. No significant additional cooperativity 
appeared to be present for any analogue duplex. 
 Next, we investigated how the overall structure of the duplex is affected by 
incorporation of these analogues by CD spectroscopy (Figure 4). All of the spectra 
suggest the presence of B-form helices. The CD spectra for the native duplex 1 and 
duplex 6 containing four dc3A residues are the most alike of the four spectra, suggesting 
similar chromophoric stacking (dA vs dc3A) within the helix. The interactions of the 
purine heterocycles are dramatically different for duplex 7, in which four methyl groups 
have been added to the central core of base pairs. This spectrum suggests a quite different 
stacking of the dmc3A chromophores, leading to dramatic shifts in the magnitude of the 
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Figure 3. Alpha plots comparing the native sequence, d(GGCC AAAA CGCC) (squares), and one 
amc3A substitution, d(GGCC AAA
CH2NH3+
A CGCC) (circles). The melting curve of the native is 63.4 
o
C and that of the amino-substituted oligo is 62.9 
o
C. 
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positive and negative displacements in the observed CD spectrum. The spectrum for 
duplex 8 (4 dhmc3A) is intermediate in character relative to those of duplexes 6 and 7. It 
seems likely that the minor-groove interactions present with the structural water mimic 
drive the conformation back toward a more native-like B-form, but much like the 
temperature data, the final native B-like structure is not fully attained. Lastly, the 
spectrum of duplex 9 shows complete disturbance of B-form DNA. The spectrum directly 
relates to the temperature data for duplex 9, further supporting that sequential cations in 
the minor groove do not offer stability or structural integrity to the helix.  
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Figure 4. CD spectra (ellipticity versus wavelength) at 3 uM concentration 
of duplexes 1, 6, 7, 8, and 9 
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3.4 Conclusions 
 Use of tetramethylsuccinimide as a directing and protecting group allows 
synthetic access of minor groove modified nucleosides in higher yields than their 
corresponding chloro-derivatives. These modified nucleosides can be elaborated to their 
corresponding phosphamidites and used for chemical synthesis of DNA. Deletion of the 
N3 nitrogen on adenine (dc3A) destabilizes the helix, but not as much as incorporation of 
steric bulk resulting from incorporation of dmc3A. Tethering functional groups that 
mimic water (dhmc3A) or ammonium (damc3A) binding in the minor groove increases 
the steric size of these minor groove substitutions, so the overall effect is still 
destabilizing relative to the native sequence. However, stabilization relative to sequences 
containing dmc3A support that small molecule binding in the minor groove is important 
to the overall stability of duplex DNA.  
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Experimental 
4-Hydroxy-3-nitropyridine (2).2 Fuming nitric acid (58 mL, >99.5%) was slowly added 
to fuming sulfuric acid (49 mL, 26-29.5% free SO3) at 0 °C. This was followed by the 
addition of 4-hydroxypyridine (20 g, 210 mmol) portion wise over 15 min. The reaction 
was slowly heated until the exothermic evolution of N2O4 occurred. The heat source was 
removed and after the reaction slowed, the mixture was heated to 120 °C for 1 h. The 
reaction mixture was cooled to ambient temperature and poured slowly over ice. The 
mixture was neutralized with conc. NH4OH and chilled overnight. Yellow crystals were 
collected by filtration and washed with a small amount of ice water to yield 24 (21.3 g, 
72%). 1H NMR (400 MHz, DMSO-d6) δ 8.78 (s, 1H); 8.52 (s, 1H); 7.76 (d, J = 7.6 Hz 
1H); 6.46 (d, J = 7.6 Hz, 1H). HRMS (ESI-TOF): calcd for C5H5N2O3: 141.03002, found: 
141.02987.  
4-Ethoxy-3-nitropyridine (3)3. To PCl5 (50.1 g, 237 mmol) dissolved in dichloroethane 
(180 mL) was added 4-hydroxy-3-nitropyridine (27.7 g, 197 mmol) and the solution was 
refluxed for 7 h. After the reaction was complete (verified by TLC, 7:3:1 
EtOAc:MeOH:28% aq. NH3), the mixture was cooled to 0 °C and 111 mL of absolute 
ethanol was added slowly via a syringe with vigorous stirring. A thick, white slurry 
formed with an increase in temperature. The slurry was stirred at 0 °C for 20 min and 
then refluxed for 1 h. The flask was cooled at 4 °C for 2–3 h, filtered and washed with 
cold ethanol to yield white crystals of 20 as the HCl salt (32.24 g, 80% (87% reported)) 
after drying in vacuo. 1H NMR (400 MHz, DMSO-d6): δ 9.10 (s, 1H); 8.91 (bs, 1H); 8.74 
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(d, J = 6.4 Hz, 1H); 7.56 (d, J = 6.4 Hz, 1H); 4.39 (q, J = 6.8 Hz, 2H); 1.38 (t, J = 7.2 Hz, 
3H). HRMS (ESI-TOF): calcd for C7H9N2O3: 169.06132, found: 169.06137.  
4-Amino-3-nitropyridine (4)3 Ammonium acetate (14.7 g, 191 mmol) was dissolved in 
water (24 mL) and 4-ethoxy-3-nitropyridine hydrochloride (9.81 g, 47.9 mmol) was 
added. The solution was refluxed for 4–8 h. The reaction was monitored by TLC (10:1 
EtOAc:triethylamine) and additional ammonium acetate was added if necessary. When 
the reaction was complete, the mixture was cooled to ambient temperature and adjusted 
to pH 8 with NH4OH and stirred for 1 h at 0 °C. The resulting precipitate was filtered and 
dried overnight to yield 19 as a yellow powder (6.58 g, 97%). 1H NMR (400 MHz, 
DMSO-d6) δ 8.97 (s, 1H); 8.13 (d, J = 6.0 Hz, 1H); 7.93 (bs, 2H); 6.89 (d, J = 6.0 Hz, 
1H). HRMS (ESI-TOF): calcd for C5H6N3O2: 140.04500, found: 140.04663.  
3,4-diamino-2-chloropyridine (5)4,5 To 25 mL of conc. HCl was added SnCl2 (33.1 g, 
175 mmol) followed by 4-amino-3-nitropyridine (5.0 g, 35.7 mmol) added portion wise 
to the solution over 10 minutes. The reaction was then refluxed for 1.5 h, after which 
TLC (9:1 DCM:MeOH) of a neutralized aliquot extracted with EtOAc showed complete 
conversion. The reaction was then cooled to ambient temperature and poured over 400 
mL of crushed ice. The solution was neutralized with 7 M NaOH and diluted with 200 
mL of water to dissolve most of the thick white precipitate that formed. Additional NaOH 
was added to maintain the pH at ~12. The slurry was extracted with ethyl acetate (4 x 100 
mL), dried over MgSO4, and evaporated in vacuo to yield 17 as a white to rose-colored 
solid that was used without further purification (3.78 g, 73%). 1H NMR (400 MHz, 
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DMSO-d6): δ 7.28 (d, J = 5.2 Hz, 1H); 6.43 (d, J = 5.2 Hz, 1H); 5.76 (s, 2H); 4.66 (s, 
2H). HRMS (ESI-TOF): calcd for C5H7ClN3: 144.03285, found: 144.03290.  
4-chloro-1H-imidazo[4,5-c]pyridine (6)6 Under inert atmosphere, triethylorthoformate 
(33.3 mL, freshly distilled over sodium) and acetic anhydride (33.3 mL, fractionally 
distilled) were added to a flask containing 3,4-diamino-2-chloropyridine (6.67 g, 46 
mmol). The reaction was then heated at reflux with stirring for 1 h, cooled to ambient 
temperature, and concentrated in vacuo. The resulting yellow solid was dissolved in 
minimal 10% NaOH and heated to 95 °C for 10 minutes. The solution was then 
neutralized to pH 6 with acetic acid and cooled at 4 °C overnight. White crystals of 15 
(5.33 g, 75%) were collected by filtration, washed with cold water and dried in vacuo. 1H 
NMR (400 MHz, DMSO-d6): δ 8.44 (s, 1H); 8.01 (d, J = 5.6 Hz, 1H); 7.60 (d, J = 5.6, 
1H). HRMS (ESI-TOF): calcd for C6H5ClN3: 154.01720, found: 154.01638. 
1H-imidazo[4,5-c]pyridin-4-amine (7)6 To a flask containing 6 (200 mg, 1.31 mmol) 
was added 3.53 mL of anhydrous hydrazine and 2.35 mL of isopropanol. The mixture 
was heated to reflux for 14 h (anhydrous conditions not needed). The reaction was 
concentrated in vacuo. Water (7 mL) and Raney nickel (329 mg, CAUTION: pyrophoric, 
weighed under tared volume of water) were added and the mixture heated to reflux with 
vigorous stirring. After 1 h the mixture was filtered, while still hot, through a pad of 
Celite and the pad washed with hot water (200 mL, CAUTION: prevent leftover Raney 
Ni from drying). Evaporation of the filtrate in vacuo afforded a tan solid. The crude 
compound was purified via solid pack with flash column chromatography (10% MeOH 
and  0.7 N NH3 in DCM) to obtain 7 as a white amorphous powder (93 mg, 53%). 1H 
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NMR (400 MHz, methanol-d4): δ 7.99 (s, 1H), 7.54 (d, J = 9.2 Hz, 1H), 6.76 (d, J = 5.6 
Hz, 1H), 5.00 (bs, 2H). HRMS (ESI+): calc. 135.06707 found. 135.0651. 
N-(1H-imidazo[4,5-c]pyridin-4-yl)-2,2,3,3-tetramethylsuccinimide (8).7 To a 
flask containing 7 (93 mg, 0.693 mmol) and 2,2,3,3-tetramethylsuccinic anhydride (216 
mg, 1.39 mmol) was added pyridine (6.4 mL) and DBU ( 0.311 mL, 2.08 mmol). The 
mixture was heated to reflux until TLC indicated complete conversion of starting material 
(20 hr). Volatiles were removed in vacuo. The resulting brown oil was purified by flash 
column chromatography eluting with 95:5 DCM:MeOH to obtain 154 mg (82%) of white 
solid. The solid was thoroughly dried in vacuo and treated with 1.5 mL of SOCl2 at reflux 
for 2 hr. Volatiles were removed in vacuo; coevaporation with EtOAc (3 x 10 mL) was 
used to remove residual SOCl2. The resulting off-white solid was then purified by flash 
column chromatography eluting with 95:5 DCM:MeOH to obtain 100 mg (53%) of 8. 1H 
NMR (400 MHz, MeOH-d4): δ 8.39 (s, 1H), 8.34 (d, J = 5.2 Hz, 1H), 7.73 (d, J = 5.6 Hz, 
1H), 1.381 (s, 12H) ppm. 13C NMR (100 MHz, MeOH-d4): δ 181.79, 144.91, 142.62, 
140.43, 20.44, 19.57 ppm. HRMS (ESI+): calc. 273.13515 found. 273.13573. 
tert-butyl 7-methyl-4-(3,3,4,4-tetramethyl-2,5-dioxopyrrolidin-1-yl)-1H-imidazo[4,5-
c]pyridine-1-carboxylate and tert-butyl 7-methyl-4-(3,3,4,4-tetramethyl-2,5-
dioxopyrrolidin-1-yl)-3H-imidazo[4,5-c]pyridine-3-carboxylate (10)7 To a flask 
containing 9 (2.85 g, 9.95 mmol) was added Boc2O (3.04 g, 13.9 mmol) and DMAP (243 
mg, 1.99 mmol). DCM (52 mL) was added and the mixture stirred at rt for 30 min 
(anhydrous conditions not needed). The starting material gradually dissolved to produce a 
yellow homogeneous solution. TLC (97:3 DCM: MeOH) indicated that a small amount 
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of starting material remained. More Boc2O (1.1 g, 5 mmol) and DMAP (122 mg, 1 
mmol) were added to drive the reaction to completion. After allowing the mixture to stir 
for another 15 min, TLC indicated that no starting material remained. Volatiles were 
removed in vacuo and the residue purified by flash column chromatography eluting with 
2:1 EtOAc:Hex to afford the desired product as a white foam (3.27 g, 85%, mixture of 
N7/N9 regioisomers). 5: Rf = 0.29, 0.36 (silica gel, 97:3 DCM:MeOH); 1H NMR (400 
MHz, CDCl3): δ 8.41 (s, 0.5H), 8.39 (d, J = 0.8 Hz, 0.5H), 8.38 (s, 1H), 8.32 (d, J = 0.8 
Hz, 1H), 2.73 (d, J = 0.8 Hz, 3H), 2.63 (d, J = 0.8 Hz, 1.5H), 1.64 (s, 9H), 1.60 (s, 4.4H), 
1.39 – 1.29 (m, 17.8H) ppm; 13C NMR (101 MHz, CDCl3) δ 181.62, 181.46, 151.92, 
146.67, 146.31, 145.86, 145.27, 144.91, 143.76, 138.26, 137.65, 137.47, 130.87, 126.75, 
121.55, 86.96, 86.66, 81.05, 47.98, 46.73, 28.05, 27.98, 27.96, 27.81, 22.63, 21.66, 21.51, 
18.87, 13.67 ppm; HRMS (ESI-TOF) calcd for C20H27N4O4H+ [M+H]+ 387.20323, 
found: 387.20368.  
tert-butyl-7-(bromomethyl)-4-(3,3,4,4-tetramethyl-2,5-dioxopyrrolidin-1-yl)-1H-
imidazo[4,5-c]pyridine-1-carboxylate and tert-butyl 7-(bromomethyl)-4-(3,3,4,4- 
tetramethyl-2,5-dioxopyrrolidin-1-yl)-3H-imidazo[4,5-c]pyridine-3-carboxylate (11)7 
To a flask containing 10 (3.27 g, 8.46 mmol) was added N-bromosuccinimide (1.28 g, 7.2 
mmol, recrystallized from hot H2O), benzoyl peroxide (131 mg, 0.54 mmol), and 175 mL 
of CCl4 (reagent grade, not anhydrous). The mixture was heated to reflux with stirring. 
After 3 h additional NBS (301 mg, 1.69 mmol) and (BzO)2 (31 mg, 0.127 mmol) were 
added. The reaction was carefully monitored by TLC (97:3 DCM:MeOH) afterwards. 
After 6.5 h total the reaction was virtually complete, with only a trace of starting material 
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and a trace of undesired dibrominated product. Volatiles were removed in vacuo and the 
residue purified by flash column chromatography eluting with 1:1 Hex:EtOAc to afford 
the desired product as a white foam (2.78 g, 71%, mixture of N7/N9 regioisomers), as 
well as the dibrominated product as an off-white solid (357 mg, 7.7%, mixture of N7/N9 
regioisomers). 11: Rf = 0.36, 0.43 (silica gel, 97:3 DCM:MeOH); 1H NMR (400 MHz, 
CDCl3) δ 8.61 (s, 1H), 8.50 (s, 1H), 8.49 (s, 0.5H), 8.41 (s, 0.5H), 5.13 (s, 1H), 4.90 (s, 
2H), 1.70 (s, 4.5H), 1.62 (s, 9H), 1.42 – 1.30 (m, 18H) ppm; 13C NMR (101 MHz, 
CDCl3) δ 181.27, 181.08, 151.19, 146.01, 145.47, 144.84, 143.69, 139.70, 132.91, 
126.07, 125.29, 121.49, 87.70, 87.03, 48.02, 46.78, 29.46, 27.92, 27.88, 27.85, 23.84, 
22.45, 21.51, 21.37, 18.80 ppm; HRMS (DART-TOF) calcd for C20H26N4O4Br [M+H]+ 
467.11170, found: 467.11272. 
N-(7-((tert-butyldimethylsilyloxy)methyl)-1H-imidazo[4,5-c]pyridin-4-yl)-2,2,3,3-
tetramethylsuccinimide (12)7  To a flask containing 11 (1.117 g, 2.406 mmol) and 
NaOAc (986 mg, 12.03 mmol) was added DMF (17 mL). The mixture was heated to 60-
65 °C with stirring. Another 395 mg (4.812 mmol) of NaOAc was added after 4 h, and 
again after 6 h. After TLC indicated complete consumption of starting material, volatiles 
were removed in vacuo and 7 M NH3/MeOH (25 mL) was added. The mixture was 
allowed to stir at rt for 8 h until TLC indicated complete conversion to the free alcohol. 
Volatiles were removed in vacuo and the crude product was loaded onto a flash column. 
Elution with 9:1 DCM:MeOH afforded 639 mg (88%) of as a white amorphous solid. 
Free Alcohol, N-(7-(hydroxymethyl)-1H-imidazo[4,5-c]pyridin-4-yl)-2,2,3,3-
tetramethylsuccinimide: Rf = 0.16 (silica gel, 92.5:7.5 DCM:MeOH); 1H NMR (CD3OD, 
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500 MHz) δ 8.37 (s, 1H), 8.31 (s, 1H), 5.02 (s, 2H), 1.38 (s, 12H) ppm; 13C NMR (101 
MHz, CD3OD) δ 183.13, 172.37, 146.58, 141.83, 118.92, 61.65, 21.85, 20.63 ppm; 
HRMS (ESI-TOF) calcd for C15H19N4O3H [M+H]+ 303.14571, found: 303.14639. 
To a flask containing the free alcohol (100 mg, 0.331 mmol), TBSCl 69 mg, 0.463 
mmol), and DMAP (2 mg, 0.0165 mmol) was added DCM (1.6 mL), DMF (0.4 mL), and 
DIPEA (86 µL, 0.496 mmol). The mixture was allowed to stir at rt for 20 h, then 
concentrated in vacuo and redissolved in EtOAc (10 mL). The organic layer was washed 
with water (2 x 5 mL) and brine (5 mL), then dried over Na2SO4, filtered, and evaporated. 
The residue was purified by flash chromatography eluting with 97:3 DCM:MeOH to 
obtain 117 mg (85%) of 12 as a white amorphous solid. 12: Rf = 0.36 (silica gel, 95:5 
DCM:MeOH); 1H NMR (500 MHz, CD3OD) δ 8.38 (s, 1H), 8.35 (s, 1H), 5.17 (s, 2H), 
1.38 (s, 12H), 0.96 (s, 9H), 0.15 (s, 6H) ppm; 13C NMR (CD3OD, 126 MHz) δ 183.26, 
146.30, 139.31, 61.04, 26.33, 21.87, 19.22, -5.19 ppm; HRMS (ESI-TOF) calcd for 
C21H31N4O3SiNa [M+Na]+ 439.2141, found: 439.2138. 
N-(7-(azidomethyl)-1H-imidazo[4,5-c]pyridin-4-yl)-2,2,3,3-tetramethylsuccinimide 
(13)7 To a flask containing 11 (800 mg, 1,72mmol) and NaN3 (450 mg, 6.89 mmol) was 
added DMF (34 mL). The mixture was heated to 45 °C with stirring. After 1.5 h, TLC 
indicated complete consumption of starting material. Volatiles were removed in vacuo 
and loaded onto a flash column. Elution with 95:5 DCM:MeOH afforded 559 mg (99%) 
of 13 as a white amorphous solid. 1H NMR (acetone-d6, 500 MHz) δ 8.37 (s, 1H), 8.34 (s, 
1H), 4.92 (s, 2H), 1.35 (s, 12H) ppm; 13C NMR (101 MHz, acetone-d6) δ 180.75, 144.28, 
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140.26, 118.92, 48.53, 47.51, 20.78 ppm; HRMS (ESI-TOF) calcd for C15H18N7O2+ [M + 
H]+ 328.1522, found: 328.1536. 
General Method for Glycosylation Reactions 
 To a flask containing the desired heterocycle (8, 9, 12, 13) and NaH (1.5 eq) was 
added MeCN (final concentration of heterocycle = 0.05 M). The mixture was allowed to 
stir for 0.5 h followed by addition of α-chlorosugar 3 (1.8 eq). The reaction stirred for 2-8 
hr, after which the reaction mixture was filtered through a celite pad. Volatiles were 
removed in vacuo and the resulting crude product was purified by flash chromatography. 
All derivatives can be purified with 1:1 Hex:EtOAc to afford  the glycosylated product as 
a white foam.  
14a: Yield – 64%. 1H NMR (400 MHz, acetone-d6): δ 8.49 (s, 1H), 8.20 (d, J = 5.6 Hz, 
1H), 8.02 (d, J = 6.6 Hz, 2H), 7.92 (d, J = 6.4 Hz, 2H), 7.86 (d, J = 5.6 Hz, 1H), 7.38 (d, J 
= 8.1 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H), 6.76 (dd, J = 2.8 Hz, 5.8 Hz, 1H), 5.87 (d, J = 6.8 
Hz, 1H), 4.71(s, 3H), 3.18-3.12 (m, 1H), 3.06-3.04 (m, 1H), 2.44 (s, 3H), 2.41 (s, 3H), 
1.34 (d, J = 15.2 Hz, 12H). 13C NMR (100 MHz, acetone-d6): δ 180.87, 165.70, 165.52, 
144.27, 144.02, 143.83, 141.16, 139.82, 139.28, 138.03, 129.59, 129.52, 129.29, 129.22, 
127.10, 127.00, 108.40, 86.032, 82.65, 74.87, 64.03, 47.59, 37.42, 20.78, 20.74 ppm. 
HRMS (ESI+): calc. 625.26622 found 625.26527. 
14b: yield – 74%. Rf = 0.35 (silica gel, 97:3 DCM:MeOH); 1H NMR (acetone-d6, 600 
MHz) δ 8.56 (s, 1H), 8.13 (d, J = 0.9 Hz, 1H), 8.05 – 7.96 (m, 2H), 7.93 – 7.83 (m, 2H), 
7.40 – 7.33 (m, 2H), 7.33 – 7.24 (m, 2H), 6.90 (dd, J = 7.8, 5.8 Hz, 1H), 5.86 (dt, J = 6.3, 
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3.1 Hz, 1H), 4.76 (td, J = 4.7, 3.2 Hz, 1H), 4.71 – 4.60 (m, 2H), 3.26 (ddd, J = 14.4, 7.8, 
6.7 Hz, 1H), 3.09 (ddd, J = 14.3, 5.8, 3.0 Hz, 1H), 2.81 (s, 3H), 2.43 (s, 3H), 2.39 (s, 3H), 
1.33 (d, J = 32.6 Hz, 12H) ppm; 13C NMR (acetone-d6, 151 MHz) δ 181.76, 166.50, 
166.36, 145.18, 144.78, 143.51, 143.49, 140.30, 138.59, 138.34, 130.55, 130.38, 130.13, 
130.11, 27.99, 127.91, 119.95, 86.26, 83.39, 75.55, 64.81, 48.39, 38.59, 21.93, 21.72, 
21.61, 21.57, 21.44, 15.51 ppm; HRMS (ESI-TOF) calcd for C36H38N4O7Na+ [M + Na]+ 
661.2638, found: 661.2629. 
14c: yield – 76%. Rf = 0.35 (silica gel, 97:3 DCM:MeOH); 1H NMR (acetone-d6, 600 
MHz) δ 8.56 (s, 1H), 8.13 (d, J = 0.9 Hz, 1H), 8.05 – 7.96 (m, 2H), 7.93 – 7.83 (m, 2H), 
7.40 – 7.33 (m, 2H), 7.33 – 7.24 (m, 2H), 6.90 (dd, J = 7.8, 5.8 Hz, 1H), 5.86 (dt, J = 6.3, 
3.1 Hz, 1H), 4.76 (td, J = 4.7, 3.2 Hz, 1H), 4.71 – 4.60 (m, 2H), 3.26 (ddd, J = 14.4, 7.8, 
6.7 Hz, 1H), 3.09 (ddd, J = 14.3, 5.8, 3.0 Hz, 1H), 2.81 (s, 3H), 2.43 (s, 3H), 2.39 (s, 3H), 
1.33 (d, J = 32.6 Hz, 12H) ppm; 13C NMR (acetone-d6, 151 MHz) δ 181.76, 166.50, 
166.36, 145.18, 144.78, 143.51, 143.49, 140.30, 138.59, 138.34, 130.55, 130.38, 130.13, 
130.11, 27.99, 127.91, 119.95, 86.26, 83.39, 75.55, 64.81, 48.39, 38.59, 21.93, 21.72, 
21.61, 21.57, 21.44, 15.51 ppm; HRMS (ESI-TOF) calcd for C36H38N4O7Na+ [M + Na]+ 
661.2638, found: 661.2629. 
14d: yield – 74%. 1H NMR (acetone-d6, 500 MHz) δ 8.65 (s, 1H), 8.42 (s, 1H), 8.02 (d, J 
= 6.5 Hz, 2H), 7.87 (d, J = 5.0 Hz, 2H), 7.37 (d, J = 10.0 Hz, 2 H), 7.28 (d, J = 5.0 Hz, 
2H), 6.85 (dd, J = 10, 5.0 Hz, 1H), 5.88 (dt, J = 6.0, 3.0 Hz, 1H), 5.03 (quartet, J = 14.5, 
14.5 Hz, 2H), 4.76 (td, J = 4.7, 3.2 Hz, 1H), 4.65 – 4.64 (m, 2H), 3.29 (m, 1H), 3.12 (m, 
1H), 2.43 (s, 3H), 2.39 (s, 3H), 1.35 (d, J = 27.5 Hz, 12H) ppm; 13C NMR (acetone-d6, 
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125 MHz) δ 166.50, 166.34, 145.21, 144.79, 144.19, 143.75, 143.36, 141.08, 140.00, 
139.07, 130.60, 130.57, 130.49, 130.37, 130.14, 130.11, 127.99, 127.92, 118.09, 88.39, 
86.65, 85.49, 83.59, 76.09, 75.60, 64.957, 64.80, 50.01, 48.55, 38.42, 30.29, 21.91, 21.61, 
21.57, 21.40 ppm. HRMS (ESI-TOF) calcd for C36H38N7O7 [M + H]+ 680.28327, found: 
680.28212. 
General Method for Toluoyl Deprotection 
To an oven-dried flask containing 14a-d (0.234 mmol) was added MeOH containing 7 N 
NH3 (7 mL). The flask was tightly stoppered and the mixture allowed to stir for 20 h. 
TLC indicated complete conversion to the free sugar. Volatiles were removed in vacuo 
and the residue purified by flash chromatography eluting with 9:1 DCM:MeOH to afford 
the product  as a white foam (53 mg, 58%).  
15a: yield – 58%. 1H NMR (500 MHz, acetone-d6) δ 8.52 (s, 1H), 8.32 (d, J = 5.5 Hz, 
1H), 7.89 (d, J = 6.0 Hz, 1H), 6.48 (dd, J = 1.5 and 6.0, 1H), 4.66 (s, 1H), 4.63 (s, 1H), 
4.06 (q, J = 3.5 Hz, 1H), 3.79 (s, 2H), 2.77-2.71 (m, 1H), 2.56-2.53 (m, 1H), 1.34 (d, J = 
21, 12H) ppm. 13C NMR (100 MHz, acetone-d6): δ 180.95, 144.10, 141.00, 140.14, 
139.05, 137.93, 108.33, 88.28, 85.78, 71.20, 61.90, 47.58, 40.55, 20.93, 20.70 ppm. 
HRMS (ESI+): calc. 389.18249 found 389.18432. 
15b: yield – 82%. Rf = 0.41 (silica gel, 92.5:7.5 DCM:MeOH); 1H NMR (400 MHz, 
MeOH-d4) δ 8.73 (s, 1H), 8.18 (s, 1H), 6.71 (t, J = 6.3 Hz, 1H), 4.59 (dt, J = 6.1, 4.1 Hz, 
1H), 4.07 (q, J = 3.7 Hz, 1H), 3.74 (ddd, J = 28.9, 12.1, 3.7 Hz, 2H), 2.87 – 2.73 (m, 1H), 
2.80 (s, 3H), 2.63 – 2.51 (m, 1H), 1.40 (s, 12H) ppm; 13C NMR (MeOH-d4, 101 MHz) δ 
183.41, 145.50, 143.29, 141.25, 138.18, 137.73, 121.32, 89.40, 86.97, 71.95, 62.65, 
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41.90, 30.67, 29.53, 21.89, 21.85, 15.69 ppm; HRMS (ESI-TOF) calcd for 
C20H26N4O5Na [M+Na]+ 425.1801, found: 425.1794. 
15c: yield – 86%. Rf = 0.27 (silica gel, 94:6 DCM:MeOH); 1H NMR (MeOH-d4, 500 
MHz) δ 8.77 (s, 1H), 8.33 (s, 1H), 6.86 (t, J = 6.3 Hz, 1H), 5.17 (dd, J = 66.6, 12.8 Hz, 
2H), 4.59 (dt, J = 6.1, 4.1 Hz, 1H), 4.03 (q, J = 3.6 Hz, 1H), 3.72 (ddd, J = 33.7, 12.1, 3.6 
Hz, 2H), 2.82–2.71 (m, 1H), 2.54 (ddd, J = 13.5, 6.2, 4.4 Hz, 1H), 1.38 (brs, 12H), 0.98 – 
0.86 (m, 9H), 0.16 (s, 3H), 0.14 (s, 3H) ppm; 13C NMR (MeOH-d4, 126 MHz) δ 183.29, 
145.89, 142.17, 140.89, 139.47, 138.64, 123.94, 89.36, 87.24, 72.02, 62.70, 61.50, 42.28, 
26.32, 21.88, 21.82, 19.06, -5.02, -5.03 ppm; HRMS (ESI-TOF) calcd for 
C26H40N4O6SiNa [M+Na]+ 555.2592, found: 555.2603. 
19: yield – 73%.1H NMR (500 MHz, acetone-d6) δ 8.52 (s, 1H), 8.32 (d, J = 5.5 Hz, 1H), 
7.89 (d, J = 6.0 Hz, 1H), 6.48 (dd, J = 1.5 and 6.0, 1H), 4.66 (s, 1H), 4.63 (s, 1H), 4.06 
(q, J = 3.5 Hz, 1H), 3.79 (s, 2H), 2.77-2.71 (m, 1H), 2.56-2.53 (m, 1H), 1.34 (d, J = 21, 
12H) ppm. 13C NMR (100 MHz, acetone-d6): δ 180.95, 144.10, 141.00, 140.14, 139.05, 
137.93, 108.33, 88.28, 85.78, 71.20, 61.90, 47.58, 40.55, 20.93, 20.70 ppm. HRMS (ESI-
TOF): calc. 389.18249 found 389.18432. 
General Method for Dimethoxytrityl-Protection 
To a flask containing the deprotected sugar (15a-c, 20, 0.45 mmol) and DMTr-Cl (1.2 eq, 
0.53 mmol) was added pyridine (9 mL). The solution was allowed to stir for 6 hr. TLC 
(95:5 DCM:MeOH) indicated complete consumption of starting material. Staining with 
10% Sulfuric Acid appeared orange at first and charred to black with heat. The reaction 
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solution was concentrated in vacuo and applied to silica gel. Column Chromatography 
with 98:2:1 DCM:MeOH:TEA afforded the protected nucleoside. 
16a: yield – 71%. 1H NMR (500 MHz, acetone-d6) δ 8.38 (s, 1H), 8.16 (d, J = 5.5 Hz, 
2H), 7.45 (d, J = 5.5 Hz, 2H), 7.33 – 7.20 (m, 7H), 6.84 – 6.82 (m, 4H), 6.72 (d, J = 6.0 
Hz, 1H), 6.50 (t, J
 
= 6.5 Hz, 1H), 4.71 (q, J = 3.5 Hz, 1), 4.21 (q, J = 5 Hz, 1H), 3.76 (s, 
6H), 3.38 (qd, J = 10, 5.5 Hz, 2H), 2.80 (m, 1H), 2.60 (m, 1H), 1.34 (d, J = 21 Hz, 12H). 
13C NMR (acetone-d6, 125 MHz) δ 180.88, 158.74, 145.05, 143.86, 140.98, 139.96, 
139.16, 138.11, 135.84, 135.69, 130.11, 128.14, 127.76, 126.74, 113.05, 108.70, 86.66, 
86.29, 85.80, 71.20, 63.92, 54.64, 47.58, 45.57, 40.15, 38.57, 20.75 ppm; HRMS 
(MALDI) calcd for C40H43N4O7 [M+H]+ 691.3126, found: 692.3135. 
16b: yield – 87%. Rf = 0.34 (silica gel, 95:5 DCM:MeOH); 1H NMR (400 MHz, 
CDCl3/pyridine-d5) δ 8.18 (d, J = 0.7 Hz, 1H), 8.16 (s, 1H), 7.38 (dd, J = 8.2, 1.3 Hz, 
2H), 7.31 – 7.11 (m, 7H), 6.79 (d, J = 8.9 Hz, 4H), 6.52 (t, J = 6.3 Hz, 1H), 4.55 (dd, J = 
9.0, 4.9 Hz, 1H), 4.16 (q, J = 4.5 Hz, 1H), 3.77 (s, 6H), 3.33 (ddd, J = 24.2, 10.2, 4.7 Hz, 
2H), 2.66 (s, 3H), 2.52 (t, J = 5.7 Hz, 2H), 1.37 (d, J = 4.6 Hz, 13H) ppm; 13C NMR (101 
MHz, CDCl3/pyridine-d5) δ 181.72, 181.69, 158.69, 146.05, 144.55, 143.13, 143.08, 
142.29, 142.25, 139.55, 137.39, 137.29, 135.68, 135.60, 130.13, 130.11, 130.02, 129.98, 
129.14, 128.33, 128.15, 128.05, 127.07, 125.41, 118.50, 113.35, 86.74, 86.30, 85.21, 
85.16, 71.63, 63.77, 55.34, 55.28, 47.98, 47.94, 46.24, 41.64, 21.91, 21.86, 21.80, 21.69, 
21.54, 21.44, 21.37, 15.87, 0.12 ppm; HRMS (ESI-TOF) calcd for C41H44N4O7Na 
[M+Na]+ 727.3073, found: 727.3094. 
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16c: yield – 84%. Rf = 0.34 (silica gel, 95:5 DCM:MeOH); 1H NMR (500 MHz, 
CDCl3/pyridine-d5) δ 8.32 (s, 1H), 8.22 (s, 1H), 7.45 – 7.33 (m, 2H), 7.33 – 7.11 (m, 7H), 
6.87 – 6.69 (m, 5H), 5.02 (dd, J = 98.3, 12.8 Hz, 3H), 4.59 (q, J = 5.2 Hz, 1H), 4.16 (q, J 
= 4.6 Hz, 1H), 3.76 (s, 6H), 3.34 (qd, J = 10.2, 4.6 Hz, 2H), 2.53 (dd, J = 8.8, 3.9 Hz, 
3H), 1.38 (s, 6H), 1.36 (s, 6H), 0.90 (s, 9H), 0.11 (s 3H), 0.9 (s, 3H) ppm; 13C NMR 
(CDCl3/pyridine-d5, 125 MHz) δ 181.4, 158.5, 144.5, 142.5, 141.7, 139.3, 138.9, 137.6, 
135.7, 135.5, 130.01, 129.98, 128.1, 127.9, 126.9, 121.3, 113.2, 86.5, 85.9, 85.2, 71.2, 
63.7, 60.8, 55.2, 47.9, 46.2, 41.6, 25.8, 21.7, 21.2, 18.2, -5.1, -5.2 ppm; HRMS (ESI-
TOF) calcd for C41H44N4O7Na [M+Na]+ 857.3922, found: 857.3903. 
21: yield – 91%. 1H NMR (acetone-d6, 500 MHz) δ 8.36 (s, 1H), 8.24 (s, 1H), 7.85-6.73 
(m, 22H), 4.95 (qd, J = 19.5, 5 Hz, 2H), 4.45 (m, 2H), 4.29 (t, J = 10 Hz, 1H), 4.23 (t, J = 
7.5 Hz, 1H), 4.10 (bs, 1H), 3.75 (s, 3H), 3.71 (s, 3H), 3.11-2.95 (m, 2H), 2.41 (m, 1H), 
2.32 (m, 1H), 1.35 (d, J = 21.5 Hz, 12H). 13C NMR (acetone-d6, 126 MHz) δ 158.90, 
158.84, 158.65, 145.56, 144.88, 144.15, 144.10, 143.10, 141.22, 141.16, 138.81, 137.94, 
136.28, 136.17, 135.71, 135.70, 130.35, 130.20, 129.95, 128.27, 128.01, 127.87, 127.69, 
127.62, 127.60, 127.02, 126.84, 126.65, 125.35, 125.27, 119.87, 119.84, 113.23, 112.99, 
112.97, 87.13, 86.21, 86.05, 74.83, 66.53, 63.98, 54.62, 54.60, 47.58, 47.18, 39.78, 20.99, 
20.82, 20.71, 20.57 ppm. HRMS (ESI-TOF) calcd for C56H55N5O9Na [M+Na]+: 
964.3897, found 964.3896 
General Method for Phosphitylation 
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To a flask containing the 5'-O-DMT-protected nucleoside (16a-c or 21, 0.403 mmol) 
dissolved in MeCN (8 mL)  at 0 oC was added tetrazole (0.90 mL of 0.45 M solution in 
MeCN, 0.403 mmol) followed by 2-cyanoethyl-N,N,N,N-tetraisopropylphosphane (256 
µL, 0.807 mmol) dropwise. Conversely, N,N-Diisopropylamino-2-
cyanoethylphosphonamidic chloride (0.807 mmol) can be used without tetrazole as an 
activator. The mixture was allowed to warm up and stir at rt for 6 h, after which TLC 
indicated that the reaction was complete. Methanol (1 mL) was added and stirring 
continued for 10 min. The reaction was concentrated in vacuo and applied to silica gel 
column chromatography (gradient of 1:1 Hex:EtOAc to 100% EtOAc). Precipitation by 
slow addition of the crude mixture dissolved in minimal DCM to vigorously stirring 
hexanes at 0 °C afforded the desired phosphoramidite (17a-c, 22) as a white solid (1:1 
mixture of diasteriomers). 
17a: yield – 73%. 31P NMR (203 MHz, CDCl3) = 147.36, 146.95 ppm; HRMS (MALDI-
TOF) calcd for C49H59N6O8PK [M+K]+ calc. 930.1002, found: 930.1752. 
17b: yield – 85%. Rf = 0.41, 0.44 (silica gel, 97:3 DCM:MeOH); 1H NMR  (400 MHz, 
CDCl3/pyridine-d5) δ 8.21 (s, 1.5H), 8.18 (s, 0.5H), 7.44 – 7.33 (m, 2H), 7.33 – 7.15 (m, 
7H), 6.86 – 6.74 (m, 4H), 6.53 (dd, J = 7.4, 5.7 Hz, 1H), 4.72 – 4.55 (m, 1H), 4.34 – 4.20 
(m, 1H), 3.86 – 3.56 (m, 4H), 3.78 (s, 3H), 3.77 (s, 3H), 3.39 – 3.22 (m, 2H), 2.69 (dd, J 
= 4.6, 0.6 Hz, 3H), 2.67 – 2.50 (m, 3H), 2.44 (t, J = 6.3 Hz, 1H), 1.38 (s, 6H), 1.37 (s, 
6H), 1.23 – 1.14 (m, 9H), 1.11 (d, J = 6.8 Hz, 3H) ppm; 31P NMR (162 MHz, 
CDCl3/pyridine-d5) δ 149.44, 149.02 ppm; HRMS (ESI-TOF) calcd for C50H61N6O8PNa 
[M+Na]+ 927.4186, found: 927.4208. 
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17c: Rf = 0.41, 0.44 (silica gel, 97:3 DCM:MeOH); 1H NMR (500 MHz, 
CDCl3/pyridine-d5) = 8.32 (s, 1H), 8.22 (s, 1H), 7.45 – 7.33 (m, 2H), 7.33 – 7.11 (m, 
7H), 6.87 – 6.69 (m, 5H), 5.02 (dd, J = 98.3, 12.8 Hz, 3H), 4.59 (q, J = 5.2 Hz, 1H), 4.16 
(q, J = 4.6 Hz, 1H), 3.76 (d, J = 0.8 Hz, 6H), 3.34 (qd, J = 10.2, 4.6 Hz, 2H), 2.53 (dd, J 
= 8.8, 3.9 Hz, 3H), 1.37 (d, J = 7.0 Hz, 12H), 0.90 (s, 9H), 0.11 (s, 3H), 0.09 (s, 3H) ppm; 
31P NMR (203 MHz, CDCl3/pyridine-d5) = 149.51, 149.42 ppm; HRMS (ESI-TOF) 
calcd for C56H76N6O9PSi [M+H]+ calc. 1035.5181, found: 1035.5179. 
22: yield – 73%. 31P NMR (acetone-d6) δ 148.38, 148.31. HRMS (ESI-TOF): calcd for 
C65H72N7O10PNa [M+Na]+ 1164.4976, found 1164.4944. 
1-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-erythro-pentofuranosyl]-4-(3,3,4,4-tetramethyl- 
2,5-dioxopyrrolidin-1-yl)-7-aminomethyl-1H-imidazo[4,5-c]pyridine (18). To a flask 
containing 17 (725 mg, 1.07 mmol) was added Pd/C (110 mg, 10% wt Pd on C) and 21 
mL of EtOAc. Hydrogen gas was bubbled through the solution for 20 minutes and then 
allowed to stir under an H2 atmosphere for 20 hr. TLC (95:5 DCM:MeOH) indicated 
complete consumption of starting material. Staining with 0.2% Ninhydrin in EtOH 
verified the presence of a free amine. The suspension was filtered through celite and the 
filtrate concentrated. Column chromatography eluting with 2.5% MeOH, 1% TEA, and 
97.5% DCM afforded 458 mg of 30 in 78% yield. 1H NMR (acetone-d6, 500 MHz) δ 
8.58 (s, 1H), 8.27 (s, 1H), 8.00 (d, J = 8.5 Hz, 2H), 7.93 (d, J = 8.5 Hz, 2H), 7.39 (d, J = 
8.0 Hz, 2H), 7.32 (d, J = 8.5 Hz, 2H), 7.15 (dd, J = 14, 6 Hz, 1H), 5.84 (dt, J = 6.0, 3.0 
Hz, 1H), 5.04 (d, J = 15.5 Hz, 1H), 4.80 (d, J = 15.5 Hz, 1H), 4.71-4.65 (m, 3H), 3.12 – 
3.04 (m, 2H), 2.44 (s, 3H), 2.39 (s, 3H), 1.36 (d, J = 29 Hz, 12H) ppm. 13C NMR 
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(acetone-d6, 125 MHz) δ 165.69, 165.37, 144.36, 143.94, 142.90, 141.87, 139.45, 
138.78, 137.88, 129.62, 129.52, 129.26, 129.24, 127.16, 127.11, 122.14, 86.18, 82.45, 
75.11, 64.16, 50.48, 47.55, 38.30, 21.02, 20.85, 20.73, 20.69, 20.58. HRMS (ESI-TOF) 
calcd for C36H40N5O7 [M+H]+: 654.29277, found: 654.29418. 
1-[2-deoxy-β-D-erythro-pentofuranosyl]-4-(3,3,4,4-tetramethyl-2,5-dioxopyrrolidin- 
1-yl)-7-(fluorenylmethoxycarbonyl)aminomethyl-1H-imidazo[4,5-c]pyridine (20): To 
a flask containing 19 (213 mg, 0.511 mmol) in dioxane (776 uL) and 10% NaHCO3 (1.6 
mL) was added a solution of Fmoc-Cl (170 mg, 0.660 mmol) in dioxane (1.53 mL). The 
solution stirred for 6 hr. TLC (92:8 DCM:MeOH) indicated complete consumption of 
starting material. The reaction mixture was diluted with EtOAc (20 mL), washed with 
saturated NaHCO3 (3 x 15 mL), and dried over Na2SO4. The organic phase was filtered, 
concentrated in vacuo, and purified with column chromatography (92:8 DCM:MeOH) to 
afford 32 (285 mg, 85%) as a white foam. 1H NMR (acetone-d6, 500 MHz) δ 8.63 (s, 
1H), 8.34 (s, 1H), 7.85 – 7.27 (m, 8H), 6.69 (t, J = 5 Hz, 1H), 4.95 – 4.79 (m, 2H), 4.65 
(t, J = 3.5 Hz, 1H), 4.39 (d, J = 7 Hz, 2H), 4.27 (t, J = 4.5 Hz, 1H), 4.08 (q, J = 3.5 Hz, 
3.5 Hz, 1H), 3.77 (m, 2H), 2.88 (m, 1H), 2.66 (m, 1H), 1.37 (d, J = 26.5 Hz, 12H) ppm. 
13C NMR (acetone-d6, 125 MHz) δ 180.96, 144.22, 144.17, 143.68, 142.28, 141.93, 
138.78, 138.60, 137.88, 127.60, 127.05, 125.26, 119.96, 119.88, 119.86, 88.30, 85.73, 
70.74, 66.44, 61.72, 47.55, 47.15, 45.80, 40.85, 39.51, 20.92, 20.65, 7.92 ppm. HRMS 
(ESI-TOF) calcd for C35H37N5O7Na [M+Na]+: 662.6907, found 662.1632 
DNA Synthesis. 
 The core sequence chosen for this study d(CCGG AAAA CGCC)/d(GGCG TTTT 
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CCGG) is the same as that used in related studies.8 
The native and modified 12-mers were prepared by solid-phase DNA synthesis 
and deprotected using standard protocols except those containing hmc3A (17c). The 
analogue nucleotides could be incorporated into DNA strands with essentially the same 
coupling efficiency as the common nucleotides except for hmc3A, which coupled in 70-
80% yield using the standard wait time of 2 min during the coupling cycle. Increasing the 
wait step of the coupling cycle to 1 hour for each introduction of 17c resulted in coupling 
efficiencies of 85–90%. All newly-synthesized oligos were deprotected and cleaved from 
the CPG beads by 12–14 h treatment with concentrated ammonia at 55 °C. The solutions 
were then decanted and evaporated by speedvac, then redissolved in 4-6 mL H2O for 
HPLC purification. 
Initial purification of native and modified oligonucleotides sequences 1–8 was 
accomplished by HPLC (Oligo R3 reverse-phase C18 column, trityl on), starting with 
100% A using a linear gradient from 0 to 50% B over 28 min [A:  1 M TEAA (pH 7) in 
5% acetonitrile; B: 1 M TEAA (pH 7) in 70% acetonitrile]. The DMT-protected 12-mers 
had retention times of about 17.5 minutes, except for Sequence 7, which had a retention 
time of 24 min due to the presence of a TBS group remaining on the hydroxymethyl 
group of each residue of 17c (four total). The collected oligonucleotides were then 
reduced in volume and detritylated and/or desilylated.  
All sequences except those containing hmc3A were detritylated in 80% acetic 
acid for 30 min at 0 °C. The resulting oligonucleotides were then desalted (Sephadex G-
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10) and lyophilized. Sequences containing hmc3A were not detritylated with AcOH 
because the TBS groups were not fully cleaved after 1 h treatment at rt. Instead, after 
DMT-on HPLC purification the sequences were lyophilized and dissolved in 100 µL 
anhydrous DMSO. Then 125 µL of NEt3•3HF were added and the mixture heated at 65 
°C for 2.5 h (DMT-off conditions). Desalting of hmc3A sequences was accomplished by 
precipitation from butanol: after cooling the desilyation mixture briefly in a freezer, 1 mL 
of 1-butanol was added, followed by 25 µL of 3 M NaOAc. After vortexing for 30s the 
mixture was cooled at -70°C for 30 minutes. This was followed by centrifugation for 10 
min at 12,500 rpm. The butanol was decanted using a sterile pipette. The residue was 
rinsed with 0.75 mL ethanol twice, then dried under high vacuum in a speed-vac to 
remove traces of butanol. Sequences containing 4 hmc3A were purified again by HPLC 
(Oligo R3 as above) before use; sequences with 1 hmc3A wer used without further 
purification.  
Nucleic Acid Analysis 
 MALDI-TOF mass spectrometry was used to obtain masses of fully deprotected 
oligos. All MALDI-TOF spectra were collected on a Waters MALDI micro MX 
spectrometer in positive-ion, linear mode. The samples were prepared with 1 uL of 200 
uM stock solution of each oligonucleotide, 1 uL of ammonium citrate buffer (10 mM, pH 
= 9.4), 1 uL of 200 uM DNA standard (5’-GCT GAA TAC ATA AGA CG-3’), and 6 uL 
of saturated 3-hydroxypiccolinic acid (Sigma Aldrich). The samples were desalted with 
an ion exchange resin (Dowex 50WX8-400, NH4+ form) and spotted onto a MALDI plate 
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where they were dried at room temperature. The resulting spectra were calibrated relative 
to the +1 and +2 ions of the internal DNA standard. The results are presented below: 
Entry Sequence m/z calc m/z found 
1 d(CCGG AAAA CGCC) 3623.7 3623.5 
2 d(CCGG AAAHA CGCC) 3622.7 3622.9 
3 d(CCGG AAACH3A CGCC) 3636.7 3636.8 
4 d(CCGG AAACH2OHA CGCC) 3652.7 3652.7 
5 d(CCGG AAACH2NH3+A CGCC) 3651.7 3652.6 
6 d(CCGG AHAHAHAH CGCC) 3619.7 3619.9 
7 d(CCGG ACH3ACH3ACH3ACH3 CGCC) 3674.8 3674.8 
8 d(CCGG ACH2OHACH2OHACH2OHACH2OH CGCC) 3739.7 3739.8 
9 d(CCGG ACH2NH3+ACH2NH3+ACH2NH3+ACH2NH3+ CGCC) 3737.6 3738.9 
10 d(CCGG ACH2NH3+AACH2NH3+A CGCC) 3677.8 3679.6 
11 d(GGCG TTTT CCGG) 3667.6 3667.0 
 
Thermal Denaturation Studies 
 Thermal denaturation studies were performed in solutions of 20 mM NaH2PO4 
(pH 7.0) and 1 M NaCl with the concentrations of duplex at 5 µM). Absorbance and 
temperature values were measured with an AVIV 14DS UV-visible spectrophotometer 
equipped with digital temperature control.  The temperature of the cell compartment was 
increased in 1.0 °C/min steps (from 4 to 95 °C), and when equilibrium was reached, 
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temperature and absorbance data were collected every 1 oC.  The raw data was exported 
to the software application Microcal Origin (OriginLab Corporation, Northampton, MA) 
for determination of the melting temperature (Tm) and free energy (∆G) of each modified 
duplex. First, the Tm plot (absorbance vs temperature) was converted to an alpha (α) plot 
(fraction of molecules paired vs temperature) using the equation: 
       


            (1) 
where A is the absorbance at a given temperature, and As and Ad are the absorbance 
values for the single- and double-stranded states, respectively. The parameter 
α represents the fraction of molecules paired; the Tm is extrapolated when α = 0.5. In 
order to obtain sufficient approximations for As and Ad, the upper and lower baselines of 
the melting curve were fitted using linear least-squares fits. The thermodynamic 
parameters ∆H, ∆S, and ∆G were determined using a van’t Hoff plot (ln K vs 1/T). The 
value of K was calculated at each temperature from the α plot using the following 
equation: 
    
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            (2) 
where Ct is the total strand concentration. The thermodynamic parameters can be derived 
directly from the linear least-squares fit in which the slope is –∆Ho/R and the intercept is 
∆So/R. The free energy change (∆Go) at any temperature can be determined by using the 
following relationship: 
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CD Experiments 
CD spectra were collected on an AVIV Circular Dichroism Spectrometer (Model 420). 
Samples were prepared in a buffer containing 20 mM Phosphate Buffer, pH 7 and 1 M 
NaCl at a concentration of 3 uM duplex and annealed. Samples were scanned over a 
range 350 to 220 nm at a rate of with time constant and bandwidth parameters set at 1 s 
and 1 nm, respectively. Data were collected at 1 nm increments for each scan and an 
average of 3 scans. The collected data was subtracted from a buffer blank to generate 
each data set. 
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ABSTRACT: We describe here the synthesis and proper-
ties of A-T rich DNA containing covalently bound water
mimics located in the DNA minor groove.
Hydration in the minor groove of B-form DNA was initiallyobserved in the early crystal structures described by Dickerson
and co-workers.1,2 More recent studies3,4 have both conﬁrmed the
presence of the minor-groove spine of hydration and mapped the
primary and secondary shells and hexagonal assemblies of water
molecules. The primary water layer is hydrogen-bonded to the
adenine N3 nitrogens (and/or thymine O2 oxygens) and then
reaches across the minor groove to a second N3 nitrogen or O2
carbonyl in the opposite strand, one base pair displaced. The second
water layer bridges the oxygens of the primary hydration layer.
Perhaps more challenging to understand is the contribution of
such hydration patterns to duplex conformation and stability. Simple
deletions of the adenine N3 nitrogens5 and/or thymine O2 carbon-
yls6 selectively eliminate hydrogen-bonding sites in theminor groove.
Studies with such analogue nucleosides present in DNA have
reported destabilization of the duplex in spite of the presence of
the Watson-Crick functional groups that should permit essentially
normal complementary base pairing. CD studies7 have indicated that
in the absence of selected N3 nitrogens and O2 carbonyls, duplex
DNA readily undergoes a conformational change to a structure that is
very A-like in nature. Also notable are studies showing that the
presence of an uncompensated amino8 or carbonyl9 group in the
minor groove is dramatically destabilizing.
We have designed an analogue nucleoside (Figure 1b) that
attempts tomimic theN3-hydrated state of adenine (Figure 1a).Here
we report on the synthesis of the analogue and related compounds,
their incorporation into DNA, and the stability of duplexes containing
one or more of the “covalently hydrated” adenine residues.
Our synthetic strategy was designed to prepare the 3-deaza
and 3-deaza-3-methyl derivatives of dA as controls that would help us
better understand the eﬀects of the loss of the N3 nitrogen as well as
the eﬀects resulting from the introduction of steric bulk into the
minor groove by using the methyl-substituted analogue. The ﬁnal
synthetic target was the covalently hydrated analogue, the 3-deaza-3-
hydroxymethyl derivative. The syntheses of the 3-deaza and 3-deaza-
3-methyl heterocycles are known, and that of the 3-deaza-3-hydro-
xymethyl derivative was straightforward. The challenge in all of
the syntheses involved the glycosylation reactions. As the steric bulk
increases (even from hydrogen to methyl) at the 3-position of the
corresponding 6-chloropurine (the most common glycosylation
target), the ratio of N7- to N9-glycosylated product becomes ex-
tremely unfavorable (N7 > N9). We note that the glycosylation of
6-chloro-3-deaza-3-methylpurine was reported10 to yield the desired
N9-glycosylated product in only 20% yield. We have largely solved11
the diﬃculties related to eﬀective glycosylation of 3-substituted pu-
rines with the introduction of the tetramethylsuccinimide (M4SI)
protecting group at the 6-position of the purine (Scheme 1). This
group eﬀectively blocks access to theN7 nitrogen, causing glycosyla-
tion to occur predominantly at the desired N9 nitrogen. Notably,
with this protecting group the 3-deaza-3-(O-tributylsilyl)hydroxy-
methylpurine derivative could be glycosylated at the N9 nitrogen in
74% isolated yield (Scheme 1). The succinimide is easily hydrolyzed
after the glycosylation (or after DNA synthesis) to unmask the
6-amino group, thus avoiding the harsh conditions necessary to
convert the 6-chloro derivative to the corresponding amine. After
elaboration of the analogue nucleosides into the fully protected
phosphoramidites, they could be incorporated into DNA with
yields that were suﬃcient to prepare the desired sequences.
After ammonia deprotection and puriﬁcation of the oligonu-
cleotides, the TBS group was removed by dissolving the 12-mers
Figure 1. (a) Water molecule hydrogen-bonded to the N3 of dA as part of
the minor-groove spine of hydration. (b) Covalently bound water mimic.
Scheme 1. Glycosylation of 3-Substituted Purines Using the
Tetramethylsuccinimide (M4SI) Protecting Group
Received: November 18, 2010
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in dimethyl sulfoxide followed by treatment with ﬂuoride ion.
Conﬁrmation of the complete deprotection of the oligonucleo-
tides was obtained by mass spectral analysis.
We prepared three types of oligonucleotides: (i) those con-
taining 3-deazaadenine, (ii) those containing 3-deaza-3-methyl-
adenine, and (iii) those containing 3-deaza-3-hydroxymethyla-
denine. The design parameters were as follows: The ﬁrst modiﬁed
oligos did not contain the N3 nitrogen, a site that is used in the
formation of the spine of hydration but otherwise introduces no
unfavorable steric eﬀects. In the methyl-containing sequences, the
N3 nitrogen was also removed, and additional unfavorable steric
eﬀects were introduced into the minor groove through the pre-
sence of one or more methyl groups. In the ﬁnal sequences, hy-
droxyls were introduced onto the unfunctionalized methyls to
generate a covalently bound water mimic capable of interacting
by hydrogen bonding in the minor groove.
Thermodynamic parameters were obtained for the formation
of all duplexes (Table 1). Even the simple elimination of a single N3
nitrogen from a centrally located dA residue (duplex 2) resulted in a
2.4 C decrease in the melting temperature (TM), consistent with
previous reports.11 In that same study, the introduction of three dA
residues lacking the N3 nitrogen resulted in a 12 C change in TM,
which also compares favorably with the 12.3 C reduction in TM
observed here with four deazaadenines present (duplex 5). We then
examined the methyl-substituted sequences (duplexes 3 and 6). The
3-deaza-3-methyl analogues both lack the N3 nitrogen but also add
steric bulk within the minor groove. Introduction of a single methyl
group (duplex 3) reduced the TM value by 2.7 C relative to a
sequence containing a single 3-deaza analogue (duplex 2) and by
5.1 C relative to the unmodiﬁed standard. The presence of four
analogues containing methyls (duplex 6) reduced the TM by a
dramatic 19.0 C, attesting to the duplex instability resulting from
increased steric eﬀects in the minor groove. The hydroxymethyl
group is sterically even larger than a methyl group and could have an
evenmore dramatic destabilizing eﬀect should the hydroxy groups be
unable to take part in advantageous interactions in the minor groove.
Introduction of one -CH2OH group did result in helix destabiliza-
tion relative to the control sequence (compare the TM for duplex 4
with that for duplex 1). However, relative to the single-methyl
sequence (duplex 3), the TM for the hydroxymethyl sequence was
some 2.6 C higher. This observation is further supported by the
sequence with four-CH2OH groups (duplex 7), which exhibited a
TM 10.3 C higher than that for the sequence containing four
methyl groups. No signiﬁcant additional cooperativity appeared to
be present for any analogue duplex.
The simplest interpretation of these results is that the absence
of hydrogen-bonding acceptors in the minor groove destabilizes
the duplex as a result of disruption of the ordered spine of hydra-
tion. The presence of four methyl groups also disrupts the spine
of hydration but additionally introduces further steric eﬀects and
additional destabilization of the duplex. The sequence containing
four hydroxymethyl substituents in principle has the greatest
steric eﬀects in the minor groove, but the hydroxyl groups appear
to provide complementary stabilizing interactions through a
modiﬁed water structure guided by favorable interactions from
the -CH2OH groups. A possible interaction mimicking the
corresponding water molecule is illustrated in Figure 2.
CD spectra of the various modiﬁed helices (Figure 3) also
oﬀer some insight into the eﬀects of various analogues. All of the
spectra suggest the presence of B-form helices. The CD spectra
for the native sequence 1 and sequence 5 containing four dc3A
residues are the most alike of the four spectra, suggesting similar
chromophoric stacking (dA vs dc3A) within the helix. The
interactions of the purine heterocycles are dramatically diﬀerent
for duplex 6, in which four methyl groups have been added to the
central core of base pairs. This spectrum suggests a quite diﬀerent
stacking of the dmc3A chromophores, leading to dramatic shifts
in the positive and negative displacements in the observed CD
spectrum. The ﬁnal spectrum, for duplex 7, is intermediate in
character relative to those of duplexes 5 and 6. It seems likely that
the minor-groove interactions present with the structural water
mimic drive the conformation back toward a more nativelike
B-form, butmuch like the temperature data, the ﬁnal native B-like
structure is not fully attained.
The data presented here suggest that simple methyl groups
located at the C3 position of dA residues are suﬃcient for dra-
matic structural perturbation but that the introduction of a-OH
group as a structural water mimic assists in partial stabilization of
the analogue structure, presumably through interactions within
the minor groove.
Table 1. Thermodynamic Stabilities of Selected DNA
Duplexes
duplex sequence at 5 μM duplex TM (C) ΔG (kcal/mol)
1 d(CCGG AAAA CGCC) 63.4 -19.1( 0.6
2 d(CCGG AAAHA CGCC) 61.0 -16.4( 0.4
3 d(CCGG AAACH3A CGCC) 58.3 -14.8( 0.3
4 d(CCGG AAACH2OHA CGCC) 60.9 -16.4 ( 2.3
5 d(CCGG (AH)4 CGCC) 51.1 -13.9( 0.2
6 d(CCGG (ACH3)4 CGCC) 44.4 -10.8( 0.4
7 d(CCGG (ACH2OH)4 CGCC) 54.7 -15.2 ( 0.7
Figure 2. Structural water mimic interacting with the carbonyl of the
cross-strand dT one base pair removed.
Figure 3. CD spectra (ellipticity vs wavelength at 3 μM duplex concen-
tration) of duplexes 1 (blue), 5 (red), 6 (green), and 7 (purple) obtained
in 20 mM sodium phosphate (pH 7) and 1 M NaCl.
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Chapter 4: Fluorescent Labeling in Minor Groove of A:T Base Pair 
4.1 Fluorescent Nucleic Acids 
Labeled nucleic acids offer a mechanism to track nucleic acids in biological and 
laboratory environments. Labeling techniques include radioactive 32P phosphorylation, 
intercalation, and fluorescent tags. Radiation and intercalation pose health dangers due to 
their high toxicities; fluorescence labeling provides a safer means to DNA detection. 
Fluorescent labeling is an ideal tool to track biological processes in the cell. Small 
molecules and proteins can be covalently attached to biomolecules of interest (DNA, 
RNA, antibodies) and their interactions within their environment can be monitored by 
fluorescent properties.  Potential uses include FRET (Förster Resonance Energy 
Transfer)1 and anisotropy2 studies of protein and nucleic acid interactions. Inherent 
fluorescence of nucleic acids are limited.3 Two modes exist for labeling DNA: covalent 
and non-covalent bonds. Intercalators such as ethidium bromide, slide in between base 
pairs, but do not form a covalent bond to the duplex. The hydrophobic environment of the 
helix core causes ethidium to fluoresce, allowing binding to DNA to be monitored.  
Radiolabeling of nucleic acids can be accomplished by kinase labeling with γ-32P-ATP. 
Fluorophores are covalently bonded to the molecule of interest by either naturally or 
synthetically incorporated labeling sites  
Inherent sites for labeling are found on all three units of a nucleotide monomer, 
making site-specific labeling difficult to control. Use of synthetically modified 
nucleotides is a simpler approach to unique labeling sites in DNA.4 Amines, thiols, 
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azides, and carboxy-groups can be incorporated into nucleotides that react specifically 
with chemically activated fluorophores. Previous work has shown modification of the 
phosphodiester backbone,5,6 sugar moiety,7 and the heterocycles.8 Labeling of the 
heterocycles has only been demonstrated in the major groove to date, the minor groove of 
DNA is a novel site for fluorescence labeling. Our work with minor groove modifications 
allows for direct incorporation of labeling sites of the 3-position of 2′-deoxyadenosine 
monomers. 
Our work with tetramethylsuccinimide has offered synthetic access to a variety 
nucleosides containing functional groups of different steric sizes off the 3-position of 2′-
deoxyadenosine. We are now able to install free amines into the minor groove of DNA, 
which can be used for labeling. Expanding on this work should allow us to install free 
thiols into the minor groove as well. These groups can be reacted with fluorophores prior 
to or post-DNA synthesis to function as a new reporter group on nucleic acids. 
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4.2 Attempts at Synthesis of New Minor Groove Labeling Sites 
An abundance of fluorophores consisting of mixed and matched reporter groups 
and amine- or thiol-specific functional groups are commercially available. Our goal 
included tethering amine and thiol functionality (Figure 1) into the minor groove to 
demonstrate how reacting these sites with fluorophores can affect duplex DNA. 
Incorporation of one modified residue into DNA grants access to site-specific labeling 
within the minor groove.  Our target DNA sequence, d(GGCC AAACH2RA CGCC) offers 
a single labeling site within duplex DNA. The synthesis of damc3A phosphoramidite and 
its incorporation into DNA have been outlined in Chapter 3.  
 
 
 
 
 
Synthesis of the thiomethyl protected phosphoramidite involved much trial and 
error as selecting an appropriate protecting group proved to be rather difficult. A series of 
different groups and approaches were taken, but one theme remained consistent: slight 
heating of this reaction in the presence of thiolates led to poor yields and multiple side 
products. The optimal route involves removal of the Boc group prior to thiolate 
displacement with standard TFA:CH2Cl2 deprotection (Scheme 1) to avoid heating 
X
X = NH2, SH
X
X = NH, S
Figure 1. Labeling using amino- and thio-methyl modified 
3-deaza-2’-deoxyadenosine 
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 during the displacement reactions. Potential protecting groups that would be stable 
throughout DNA solid-phase synthesis were acetate thioester, 2,4-dinitrophenyl thioether, 
and p-methoxybenzyl thioether. The acetate group is labile to standard ammonium 
hydroxide treatment, while the 2,4-dinitrophenyl thioether requires extra treatment with 
2-mercaptoethanol (BME) to remove the protecting group.9 P-methoxybenzyl thioethers 
are used to protect cysteine residues during peptide solid phase synthesis.10 These groups 
are removed using mercuric (II) acetate in TFA in the presence of anisole.  
The thioacetate group is installed by displacement of bromo-nucleobase 2 with 
KSAc. The acetate can be removed with methanolic ammonia resulting in a free thiol, 
which can then be reacted with 2,4-dinitrofluorobenzene to give 4. The next group 
N
N-M4SI
N
N
a
1
N
N
N-M4SI
S
N
N-M4SI
S
N
N
H
N
N
H
N
N
H
Boc
N
N-M4SI
N
N
H
2
SAc3
4
5
Br Br
NO2
NO2
OMe
b
b, c, d
e
a) TFA: CH2Cl2 (1:2), rt 15 min, >90%.
b) KSAc, DMF, rt, 45 min, 86%
c) 7 N NH3 in MeOH, rt, 10 min.
d) 2,4-dinitrofluorobenzene, TEA, MeCN, rt, 3 hr, 78%
e) 4-methoxy- -toluenethiol, NaH, DMF, rt, 1.5 hr, 87%
NM4SI
Scheme 1. Synthesis of Potential Thio-Protected Nucleobases. 
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explored was installed by displacement of bromo-nucleobase 2 with 4-methoxy-α-
toluenethiol to give 5. 
The first group examined was thioacetate. The bromo-nucleobase reacted with 
KSAc to afford thioester 3 in 86% yield. Glycosylation of heterocycle 3 yielded thio-
protected nucleoside 10 in 76% yield (Scheme 2). Selective deprotection of the toluoyl 
esters could not be accomplished in the presence of the thioester. Sodium thiomethoxide 
in MeOH has been used to deprotect thioesters in the presence of O-esters,11 but 
treatment of 6 with these conditions resulted in unwanted deprotection of the toluoyl 
groups after 30 minutes. Removal of both thioacetate and the toluoyl esters with 7 N NH3 
in MeOH resulted in a crude reaction mixture that was difficult to purify as well as low 
yielding. Discriminating between O-esters and S-esters proved challenging, so new 
methods for protecting the thiol functionality were explored. 
 
 
 
 
The thioacetate displacement could be used to successfully install thio-
functionality before glycosylation. Deprotection of nucleobase 3 with 7 N NH3 afforded 
the free thiol, which could then be protected with 2,4-dinitrophenyl (DNP) thioether to 
give 4. Selective protection of the thioether proved rather difficult as the imidazole 
Scheme 2. Attempts at Selective Deprotection of Thioester in the Presences of O-esters. 
N
N
H
N
NM4SI
SAc
1) NaH, MeCN
rt, 30 min
2)
O
TolO
OTol
Cl
O
TolO
OTol
N
NM4SI
N
N
SAc
NaSMe, MeOH
or
NH3, MeOH O
TolO
OTol
N
NM4SI
N
N
SH
3
80%
6
76%
7
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moiety of the heterocycle is somewhat nucleophilic and reactive towards the protecting 
group. The reaction resulted in multiple products, including the desired product 4, but 
also β-N9 and β-N7 DNP-nucleosides. 
We next focused our efforts on p-methoxybenzyl thioether since it is commonly 
used as a protecting group for peptide solid-phase synthesis on cysteine residues. 
Displacement of the bromide with 4-methoxy-α-toluenethiolate successfully installed the 
thiol functionality and protection simultaneously to give 5. This analogue was 
successfully glycosylated and carried throughout the synthesis to phosphoramidite 13 
(Scheme 3). The phosphoramidite was incorporated into DNA with yields similar to 
those of commercially available phosphoramidites.  
Removal of the protecting group post-DNA synthesis was fruitless. Standard 
deprotection conditions call for mercuric (II) acetate in trifluoroacetic acid with anisole.12, 
13
 Treatment of DNA with TFA led to depurination of the purine nucleosides (Scheme 4). 
It was clear that TFA was too strong of an acid to use with DNA. We sought to use a 
weaker acid, such as acetic acid or even water, as the solvent with either mercuric (II) 
acetate or mercuric (II) trifluoroacetate. These attempts were also unsuccessful.  
The chosen protecting group had to be stable to ammonia in methanol conditions 
to remove the toluoyl groups, but labile to ammonium hydroxide deprotection post-DNA 
synthesis. Cyanoethyl thioethers are commonly used to protect 6-thio-2′-deoxyguanosine 
and 4-thiouracil phosphoramidites. They are used throughout DNA synthesis and 
removed with NaOH containing a small amount of NaSH,14 so this group seemed best for  
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  Scheme 3. Synthesis of p-Methoxy-Benzylthioether Phosphoramidite (9) 
Scheme 4. Depurination of Purine Residues in DNA with acid. 
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our purposes. Displacement of the bromide with potassium thioacetate afforded 3 in 
acceptable yield and was stable to glycosylation conditions, yielding 76% of the desired 
isomer (Scheme 2). The cyanoethyl protecting group could be installed in one pot by 
treatment of 6 with NH3 in methanol for 10 minutes (Scheme 5). This did lead to small 
amounts of toluoyl ester deprotection, however it seemed the most direct route to 
deprotecting the thioester. The free thiol can be treated with 3-bromopropionitrile and 
potassium carbonate in DMF to yield protected thioether 14 in 62% yield. It should be 
noted that appropriate monitoring of this reaction must take place. Long reaction times in 
DMF lead to isomerization of the β-N9 nucleoside. The toluoyl groups could then be 
removed cleanly in methanolic ammonia to give 15 in 76% yield with no thioether 
deprotection detected. Elaboration to dtc3A phosphoramidite by DMT-protection 
followed by phosphitylation resulted in phosphoramidite 17 in 63% overall yield over 2 
steps. DNA synthesis with 17 incorporated a single dtc3A residue.  
  
 
 
 
 
 
 
Scheme 5. Synthesis of 2-cyanoethyl thioether Phosphoramidite 17 
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Deprotection of the 2-cyanoethyl thioether proved rather difficult. The reaction 
proceeds via β-elimination to produce the free thiol and cyanoethene. All references to 
date show this protecting group utilized on aromatic thiols.15-17 Due to the poor leaving 
group character of the benzyllic thiol, bases such as NaOH are not strong enough to 
remove the proton α- to the nitrile group. The pKa of this proton is typically around 25, 
so much stronger bases like sodium amide must be used to effectively deprotonate the α-
position and allow β-elimination to take place. Optimally, the chosen protecting group 
will be labile to standard ammonium hydroxide treatment. Prospects on these groups and 
extensions of the work above are discussed in section 4.4 
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4.3 Fluorescent Labeling of DNA Minor Groove 
The amc3A minor-groove labeling site was reacted with specific probes after 
standard deprotection and purification of the synthesized oligos. Typical conditions 
involved reaction of 50 nmol of DNA with 20-fold molar excess of the label in a solution 
of 1:10 DMSO:Buffer (30 mM NaHCO3, pH 8.45). The reaction was incubated overnight 
at room temperature to provide the labeled oligo, which could be purified by HPLC 
(Figure 2, next page). HPLC traces of labeling reactions followed the same general 
pattern: elution of non-labeled DNA, followed by fluorescent-labeling DNA, and finally 
elution of unreacted fluorophores. The desired peak was collected, concentrated, and 
desalted using a Sep-Pak C18 cartridge (Waters, Milford, MA). Melting temperature data 
was then obtained by hybridizing the labeled oligo to its complement. 
We chose two labels differing in fluorescent tags and length of the linker (Figure 
3). DNA containing the damc3A analogue readily reacted with both Marina Blue and 
Fluorescein-5-EX succinimidyl esters in 87% yield.  
  
O
O
O
O
N OO
CH3
F
F
HO
O OHO
CO2H
HN
O
S
O
O
N OO
Marina Blue Succinimidyl Ester Fluorescein-5-EX Succinimidyl Ester
Figure 3. Amine Reactive Fluorophores 
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Figure 2. HPLC traces of unmodified  amc3A DNA (top), 
labeling reaction with Fluorescein-5-EX (middle) and pure 
Fluorescein-5-EX succinimidyl ester (bottom). 
110 
 
The results of fluorescent labeling in the minor groove are shown in Table 1.  
Labeling with Marina Blue adds 2.9 oC to the amino-control sequence and 2.4 oC to the 
native sequence, suggesting this fluorophores acts to stabilize the helix. This can be 
attributed to dynamic intercalation; intercalators are positively charged and this 
fluorophore is neutral. It is thought that the fluorophore slides in and out of the base pairs, 
offering some additional stability, but because it is dynamic, it is not technically an 
intercalator. Amino-labeling with fluorescein-5-EX decreases the melting temperature, 
TM, by 4.1 oC relative to the amino-substituted oligo. This may be attributed to the 
additional length of linker or the larger size of the fluorophores as compared to Marina 
Blue.  
Table 1. Melting Temperatures of Minor Groove Labeled DNA 
Sequence Fluorophore TM
† 
d(CCGG AAAA CGCC) --- 63.4 
d(CCGG AAA
CH2NH2
A CGCC) --- 62.9 
d(CCGG AAA
CH2NH-MB
A CGCC) Marina Blue 65.8 
d(CCGG AAA
CH2NH-F5EX
A CGCC) Fluorescein-5-EX 58.8 
† 
5 uM concentration of duplex, 20 mM Phosphate Buffer, pH 7, 1 M NaCl. 
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4.4 Conclusions and Future Work 
The work described throughout this thesis details how minor groove 
modifications can be used to study the minor groove of DNA. Tetramethylsuccinimide is 
a valuable asset to accessing synthetic modifications on the 3-position of 2′-
deoxyadenosine prior to glycosylations. Previous to this work, few modifications in the 
minor groove of A-T base pairs existed, especially those presenting somewhat sterically 
large substituents.  
The modifications presented in Chapter 2, Figure 2 were designed to study how 
small molecules such as water and ammonium cations bind to A-tract DNA in the minor 
groove. The results presented in Chapter 3 show that these molecules contribute 
somewhat to the structure and stability of duplex DNA. Further study of molecules 
binding in the minor groove arises from aminomethyl (damc3A) and thiomethyl (dtc3A). 
These two analogues can be treated with amine or thiol specific fluorophores to give rise 
to a new site for labeling within DNA. Minor groove labeling has not been shown before, 
but can be used to study how molecules, such as proteins and drugs, bind to the region of 
duplex DNA. Currently, need protecting groups and deprotection methods are being 
explored for tmc3A incorporation into DNA. Possible deprotection with sodium amide or 
other NR2- bases may function to deprotonate the α-proton on the 2-cyanoethyl 
protecting group, but these conditions are rather dangerous and difficult to work with 
safely.  
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New approaches to successful installation of tmc3A into DNA include changing 
the structure or synthetic route of the thiomethyl derivative (Scheme 6).   If the 
methylene unit is removed the the thiol moiety is directly attached to the nucleobase, this 
should activate the leaving group enough to allow for deprotection to occur under 
standard conditions. A reaction that has not been explored is coupling the 3-deaza-3-
methylbromopurine to the sugar. If this reaction is successful, the toluoyls can be 
removed prior to thioacetate displacement. This would allow direct elaboration to the 
phosphoramidite by DMT protection and phosphitylation.  
On-going and future work for this project also includes expansion of protecting 
and directing groups for purine glycosylations as shown in Chapter 2,4. The ultimate goal 
is two-fold: i) to increase the aliphatic character of the protecting group as to make these 
protected nucleobases more soluble in non-polar solvents and ii) increase the steric size 
of the substituents of the succinimide group to more effectively block the N7-position 
during glycosylation. Meetings these goals would increase the overall yield of desired β-
Scheme 6. Proposed Steps towards new tmc3A Analogues. 
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N9 isomer and give way to more commercially available modified nucleosides at modest 
pricing.  
In order to expand our studies on how small molecules bind the minor groove, 
current work involves expanding the linker of the functional groups by one methylene 
unit (Figure 4). It remains uncertain whether one methylene unit is an adequate linker to 
permit the hydroxyl group to reach across the helix to hydrogen bond with the O2-
carbonyl of thymidine, one base pair displaced. Results from these studies will reveal in 
more detail the required length of linker for optimal hydrogen bonding.  
 
 
  
 
Factors that stabilize or disturb duplex formation are important in the design of 
molecules targeted towards DNA. Our research demonstrates that water and ammonium 
binding play a role in stabilizing the thermodynamic parameters and structural integrity 
of duplex DNA. The key to synthesizing these important analogues is 
tetramethylsuccinimide as a directing and protecting group. The results from these studies 
have enabled researchers to gain insight into the minor groove in ways that was 
previously not established. 
  
NN
N
H
NH2
OH
NN
N
H
NH2
NH3
Figure 4. Extension of Minor Groove Modification by One Methylene Unit. 
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4.5 Experimental 
N-(7-(acetylthiomethyl)-1H-imidazo[4,5-c]pyridin-4-yl)-2,2,3,3-
tetramethylsuccinimide (3). The Boc group wass first removed by dissolving bromo-
nucleobase 1 (1.58 g, 3.42 mmol) in CH2Cl2 (20 mL) and adding TFA (10 mL). After 10 
min, TLC (1:1 Hex:EtOAc) indicated complete consumption of starting material. Water 
(10 mL) was added and the solution was transferred to a separatory funnel. After 
vigorous shaking, the organic layer was separated and washed with sat. NaHCO3 (2 x 10 
mL). The organic layer was dried over Na2SO4, filtered and concentrated to yield 938 mg 
(77%) of the deprotected, bromo-substituted nucleobase 2. This nucleobase (500 mg, 
1.37 mmol) was dissolved in DMF and KSAc was added (235 mg, 2.06 mmol). The 
solution stirred for 1 hr at room temperature upon which time TLC indicated complete 
conversion to 1. DMF was removed in vacuo and the crude product was applied to silica 
gel chromatography. Elution with 5% MeOH in DCM produces 424 mg (86%) of the title 
compound as a white solid. 1H NMR (500 MHz, acetone-d6) δ 8.31 (s, 1H), 8.30 (s, 1H), 
4.48 (s, 2H), 2.36 (s, 3H), 1.32 (s, 12H).  13C NMR (126 MHz, acetone-d6) δ 190.99, 
180.90, 143.81, 143.68, 141.15, 138.16, 137.03, 119.53, 47.55, 26.77, 20.83, 20.66 ppm. 
HRMS (ESI-TOF) calcd for C17H21N4O3S [M+H]+ 361.1334, found 361.1335. 
1-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-erythro-pentofuranosyl]-4-(3,3,4,4-
tetramethyl-2,5-dioxopyrrolidin-1-yl)-7-acetylthiomethyl-1H-imidazo[4,5-c]pyridine 
(10). To a flask containing 3 (83 mg, 0.230 mmol) and NaH (17 mg, 0.345 mmol, 50% 
dispersion in oil) was added 5 mL of MeCN. The mixture was allowed to stir for 45 min. 
The α-chloroprotected sugar (161 mg, 0.414 mmol) was added and stirring continued for 
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2 h. The reaction mixture was filtered and volatiles were removed in vacuo and the 
resulting yellow foam was purified by flash chromatography eluting with 1:1 
Hexanes:EtOAc to afford 125 mg (76%) of 10 as a white foam. 1H NMR (500 MHz, 
acetone-d6) δ 8.61 (s, 1H), 8.33 (s, 1H), 8.01 (d, J = 9 Hz, 2H), 7.86 (d, J = 8 Hz, 2H), 
7.34 (d, J = 8.5 Hz, 2H), 7.26 (d, J = 8 Hz, 2H), 6.89 (dd, J = 5, 3, 5.5 Hz, 1H), 5.82 (m, 
1H), 4.80 (d, J  = 14.5, 1H), 4.73 (m, 1H), 4.63 (d, J = 4.5 Hz, 2H), 4.60 (d, J = 14.5 Hz, 
1H), 3.23 (m, 1H), 3.11 (m, 1H), 2.39 (s, 3H), 2.38 (s, 3H), 2.35 (s, 3H), 1.32 (d, J = 27.5 
Hz, 12H) ppm. 13C NMR (126 MHz, acetone-d6) δ 193.51, 180.59, 165.49, 144.34, 
143.92, 143.51, 143.29, 139.07, 138.65, 138.05, 129.75, 129.72, 129.66, 129.52, 129.26, 
129.24, 127.12, 127.03, 118.86, 85.63, 82.75, 74.79, 63.99, 47.62, 37.54, 27.29, 21.01, 
20.82, 20.75, 20.73, 20.71, 20.55 ppm. HRMS (ESI-TOF) calcd for C38H40N4O8SNa+ [M 
+ Na]+ 735.2465, found: 735.2465. 
1-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-erythro-pentofuranosyl]-4-(3,3,4,4-
tetramethyl- 
2,5-dioxopyrrolidin-1-yl)-7-(2-cyanoethyl)thiomethyl-1H-imidazo[4,5-
c]pyridine (12). To a flask containing 10 (50 mg, 0.070 mmol) was added MeOH 
containing 7 M NH3 (1 mL). The flask was tightly stoppered and the mixture allowed to 
stir for 10 min. TLC indicated complete consumption of 10 and the solution was 
concentrated in vacuo. The free thiol was then protected by dissolving the product in 
DMF (700 uL) and addition of 3-bromopropionitrile (6 uL, 0.70 mmol) in the presence of 
K2CO3 (19 mg, 0.14mmol). The solution stirred for 10 hr and was then concentrated. 
Flash column chromatography (9:1 DCM:MeOH) gave 31 mg (62%) of pure 12. 1H 
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NMR (500 MHz, acetone-d6) δ 8.61 (s, 1H), 8.31 (s, 1H), 8.04 (d, J = 5 Hz, 2H), 7.89 (d, 
J = 7.5 Hz, 2H), 7.40 (d, J = 8.5 Hz, 2H), 7.30 (d, J = 5.5 Hz, 2H), 7.02 (dd, J  = 13.5, 5.5 
Hz, 1H), 5.89 (q, J = 12, 3 Hz, 1H), 4.81 (q, J = 12.5, 2.5 Hz, 1H), 4.66 (d, J = 5 Hz, 2H), 
4.60 (d, J = 13.5 Hz, 1H), 4.37 (d, J = 13.5 Hz, 1H), 3.28-3.25 (m, 1H), 3.21-3.18 (m, 
1H), 2.95 (m, 4H),  2.42 (s, 3H), 2.39 (s, 3H), 1.36 (d, J = 26.5 Hz, 12H). 13C NMR (126 
MHz, acetone-d6) δ 165.61, 165.44, 144.32, 143.90, 143.24, 142.93, 139.28, 138.80, 
138.21, 129.66, 129.48, 129.28, 129.23, 127.10, 127.01, 119.17, 118.57, 86.00, 82.63, 
74.76, 63.92, 47.60, 37.63, 27.08, 20.99, 20.71, 20.66, 20.51, 17.98. HRMS (ESI-TOF) 
calcd for C39H42N5O7S [M+H]+ 724.2805, found 724.2778. 
 
1-[2-deoxy-β-D-erythro-pentofuranosyl]-4-(3,3,4,4-tetramethyl-2,5-
dioxopyrrolidin- 
1-yl)-7-(2-cyanoethyl)thiomethyl-1H-imidazo[4,5-c]pyridine (13). To a flask 
containing 12 (50 mg, 0.069 mmol) was added MeOH containing 7 M NH3 (1.5 mL). The 
flask was tightly stoppered and the mixture allowed to stir for 14 h. Volatiles were 
removed in vacuo and the residue purified by flash chromatography eluting with 8% 
MeOH in DCM to afford 13 as a white foam (26 mg, 76%). 1H NMR (acetone-d6, 500 
MHz) δ 8.63 (s, 1H), 8.28 (s, 1H), 6.79 (t, J = 6.5 Hz, 1H), 4.69 (q, J = 9.5, 2 Hz, 1H), 
4.51 (d, J = 13 Hz, 1H), 4.30 (d, J = 13.5 Hz, 1H), 4.11 (q, J = 7, 3.5 Hz 1H), 3.77 (m, 
2H), 2.91-2.85 (m, 5H), 2.73 (m, 1H), 1.36 (d, J = 26 Hz, 12H) ppm. 13C NMR (acetone-
d6, 125 MHz) δ 181.21, 143.89, 141.63, 139.37, 138.42, 137.76, 122.33, 88.00, 85.99, 
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70.52, 61.53, 50.14, 47.58, 31.37, 21.05, 20.89 ppm; 13C NMR (126 MHz, acetone-d6) 
δ 180.89, 143.86, 142.47, 138.99, 138.68, 138.20, 119.14, 118.65, 88.39, 86.01, 71.01,  
61.76, 47.57, 27.11, 20.91, 20.64, 17.95. HRMS (ESI-TOF) calcd for 
C23H30N5O5S [M+H]+ 488.1968, found 488.1957. 
 
1-[5’-O-(4,4’-dimethoxytrityl)-2-deoxy-β-D-erythro-pentofuranosyl]-4-
(3,3,4,4-tetramethyl- 
2,5-dioxopyrrolidin-1-yl)-7-(2-cyanoethyl)thiomethyl-1H-imidazo[4,5-
c]pyridine (14): To a flask containing 13 (74 mg, 0.152 mmol) and DMTr-Cl (61 mg, 
0.182 mmol) was added pyridine (3 mL). The solution was allowed to stir for 4 hr. TLC 
(95:5 DCM:MeOH) indicated complete consumption of starting material. The reaction 
solution was concentrated in vacuo and applied to silica gel. Column Chromatography 
with 1% TEA in EtOAc afforded 104 mg (87%) of the DMT-protected nucleoside 14. 1H 
NMR (acetone-d6, 500 MHz) δ 8.47 (s, 1H), 8.33 (s, 1H), 7.39-6.77 (m, 14H), 4.71 (q, J 
= 4.5, 3.5 Hz, 1H), 4.63 (d, J = 13.5 Hz, 1H), 4.34 (d, J = 13.5 Hz, 1H), 4.26 (q, J = 4, 3 
Hz, 1H), 4.03 (m, 1H), 3.74 (s, 6H), 3.30 (d, J = 4 Hz, 2H), 3.00 (m, 1H), 2.92 (m, 4H), 
2.77 (m, 1H), 1.36 (d, J = 27 Hz, 12H) ppm.13C NMR (acetone-d6, 126 MHz) δ  180.89, 
158.67, 144.99, 143.31, 142.60, 139.14, 138.88, 138.41, 135.70, 130.00, 129.96, 128.00, 
127.69, 126.66, 119.33, 118.65, 113.00, 86.65, 86.10, 85.70, 71.02, 63.98, 63.55, 54.61, 
47.59, 39.90, 27.08, 21.09, 20.83, 20.71, 20.46, 19.90, 18.86, 17.94, 13.62, 13.07 ppm. 
HRMS (MALDI-TOF) calcd for C45H50N6O8SNa [M+Na]+ 812.3088, found 812.3103. 
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3-deaza-3-thiomethyl-2’-deoxyadenosine phosphoramidite 15. To a flask 
containing 5'-O-DMT-protected 14 (72 mg, 0.091 mmol) dissolved in MeCN (1.8 mL)  at 
0 oC was added tetrazole (303 uL of 0.45 M solution in MeCN, 0.136 mmol) followed by 
2-cyanoethyl-N,N,N,N-tetraisopropylphosphane (87 µL, 0.274 mmol) dropwise. The 
mixture was allowed to warm up and stir at rt for 6 h, after which TLC indicated that the 
reaction was complete. Methanol (1 mL) was added and stirring continued for 10 min. 
The reaction was concentrated in vacuo and applied to silica gel column chromatography 
(gradient of 40% Hexanes, 1% TEA, 59% EtOAc to 100% EtOAc). Precipitation by slow 
addition of the crude mixture dissolved in minimal DCM to vigorously stirring hexanes 
followed by cooling at 0 °C for 30 min afforded 6 as a white solid (65 mg, 72%, 1:1 
mixture of diasteriomers). 31P NMR (acetone-d6) δ 148.66, 148.50.  
DNA Synthesis. 
 The sequence used for this study is the same as those described in Chapter 
3, d(CCGG AAAA CGCC). A single modification of the third A with dtmc3A afforded a 
non-self complementary oligomer with one specific site used for fluorescence labeling. 
The modified 12-mers was prepared by solid-phase DNA synthesis and deprotected using 
standard protocols. The analogue nucleotide 15 could be incorporated into DNA strands 
with essentially the same coupling efficiency as the common nucleotides using the 
standard wait time of 2 min during the coupling cycle. The oligo was deprotected and 
cleaved from the CPG beads by 16 h treatment with concentrated ammonia at 55 °C. The 
solutions were then decanted and evaporated by speedvac, then redissolved in 4-6 mL 
H2O for HPLC purification. 
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Initial purification the modified oligonucleotide was accomplished by HPLC 
(Oligo R3 reverse-phase C18 column, trityl on), starting with 100% A using a linear 
gradient from 0 to 50% B over 28 min [A:  1 M TEAA (pH 7) in 5% acetonitrile; B: 1 M 
TEAA (pH 7) in 70% acetonitrile]. The DMT-protected 12-mer had retention times of 
about 15 minutes. The corresponding peak was collected and then reduced in volume and 
detritylated.  
Detritylation in 80% acetic acid for 60 min at 0 °C, followed by desalting 
(Sephadex G-10) and lyophilization gave the dtmc3A modified oligomer as a white 
powder. Mass Spectral Analysis (MALDI-TOF) showed a peak corresponding to the 
dtmc3A oligomer with the 2-cyanoethyl protecting group still present. Further treatment 
of this oligo in 1 M NaOH at 50 oC was monitored by HPLC until the retention time of 
the peak shifted from 12.8 minutes to 10.2 minutes (Waters C18 Column, 0 to 100% B 
over 60 min. A: 50 mM TEAA, pH 7, 5% Acetonitrile; B: 50 mM TEAA, pH 7, 70% 
Acetonitrile). 
Fluorescent Labeling 
 To begin, 50 nmol of singly modified damc3A or dtmc3A oligomers were 
lyophilized. The label was prepared by dissolving 1 mg in 100 uL of DMSO. The 
lyophilized oligo was dissolved in 90 uL buffer (30 mM NaHCO3, pH 8.45 for damc3A 
and 40 mM Phosphate Buffer, pH 9.2 for dtc3A) and 10 uL of the label (about 10-20 
molar equivalents) was added to the DNA solution. The damc3A containing reactions 
were allowed to sit overnight at room temperature on a shaker plate, while the dtmc3A 
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containing reactions were allowed to react for 3 hr at room temperature. 
 The newly labeled oligomers were purified from unreacted oligo and label 
via HPLC (Waters C18 Column, 0 to 100% B over 60 min. A: 50 mM TEAA, pH 7, 5% 
Acetonitrile; B: 50 mM TEAA, pH 7, 70% Acetonitrile). Unmodified oligos had 
retention times from 10-15 minutes, while labeled oligos had retention times of 15-18 
minutes. The unreacted fluorophores eluted last between 22 and 25 minutes. The desired 
peak was collected and any acetonitrile was removed in vacuo. The solution was then 
desalted via C18 Sep Pak (Waters) and lyophilized. 
Thermal Denaturation Studies 
 Thermal denaturation studies were performed in solutions of 20 mM 
NaH2PO4 (pH 7.0) and 1 M NaCl with the concentrations of duplex at 5 µM). 
Absorbance and temperature values were measured with an AVIV 14DS UV-visible 
spectrophotometer equipped with digital temperature control.  The temperature of the cell 
compartment was increased in 1.0 °C/min steps (from 4 to 95 °C), and when equilibrium 
was reached, temperature and absorbance data were collected every 1 oC.  The raw data 
was exported to the software application Microcal Origin (OriginLab Corporation, 
Northampton, MA) for determination of the melting temperature (Tm) and free energy 
(∆G) of each modified duplex. First, the Tm plot (absorbance vs temperature) was 
converted to an alpha (α) plot (fraction of molecules paired vs temperature) using the 
equation: 
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            (1) 
where A is the absorbance at a given temperature, and As and Ad are the 
absorbance values for the single- and double-stranded states, respectively. The parameter 
α represents the fraction of molecules paired; the Tm is extrapolated when α = 0.5. In 
order to obtain sufficient approximations for As and Ad, the upper and lower baselines of 
the melting curve were fitted using linear least-squares fits. The thermodynamic 
parameters ∆H, ∆S, and ∆G were determined using a van’t Hoff plot (ln K vs 1/T). The 
value of K was calculated at each temperature from the α plot using the following 
equation: 
    

	

            (2) 
where Ct is the total strand concentration. The thermodynamic parameters can be 
derived directly from the linear least-squares fit in which the slope is –∆Ho/R and the 
intercept is ∆So/R. The free energy change (∆Go) at any temperature can be determined 
by using the following relationship: 
      ∆°   ∆°  ∆°            (3) 
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Appendix  1: NMR Spectra 
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Appendix II: α-Plots and van Hoft Analysis of Oligonucleotides 
 
Thermal denaturation studies were performed in solutions of 20 mM NaH2PO4 
(pH 7.0) and 1 M NaCl with the concentrations of duplex at 5 µM). Absorbance and 
temperature values were measured with an AVIV 14DS UV-visible spectrophotometer 
equipped with digital temperature control.  The temperature of the cell compartment was 
increased in 1.0 °C/min steps (from 4 to 95 °C), and when equilibrium was reached, 
temperature and absorbance data were collected every 1 oC.  The raw data was exported 
to the software application Microcal Origin (OriginLab Corporation, Northampton, MA) 
for determination of the melting temperature (Tm) and free energy (∆G) of each modified 
duplex. First, the Tm plot (absorbance vs temperature) was converted to an alpha (α) plot 
(fraction of molecules paired vs temperature) using the equation: 
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            (1) 
where A is the absorbance at a given temperature, and As and Ad are the absorbance 
values for the single- and double-stranded states, respectively. The parameter 
α represents the fraction of molecules paired; the Tm is extrapolated when α = 0.5. In 
order to obtain sufficient approximations for As and Ad, the upper and lower baselines of 
the melting curve were fitted using linear least-squares fits. The thermodynamic 
parameters ∆H, ∆S, and ∆G were determined using a van’t Hoff plot (ln K vs 1/T). The 
value of K was calculated at each temperature from the α plot using the following 
equation: 
    
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            (2) 
where Ct is the total strand concentration. The thermodynamic parameters can be derived 
directly from the linear least-squares fit in which the slope is –∆Ho/R and the intercept is 
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∆So/R. The free energy change (∆Go) at any temperature can be determined by using the 
following relationship: 
          ∆°   ∆°  ∆°            (3) 
d(CCGG AAAA CGCC)
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d(CCGG (AH)4 CGCC) 
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d(CCGG ACH2NH3+AACH2NH3+A CGCC) 
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d(CCGG AAACH2NHRA CGCC) with Marina Blue 
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d(CCGG AAACH2NHRA CGCC) with Fluorescein-5-EX 
It should be noted that the presence of the fluorescein-5-EX group severely 
distorts the sigmoidal shape of the oligo’s melting curve. Methods for calculating 
α- plots and van Hoft plots are inapplicable to this type of curve. The melting 
temperature is extrapolated from the positively sloped line. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
